Document:

cmbg_ex101.htm

Exhibit 10.1

 

CELLULAR BIOMEDICINE GROUP, INC.

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement (the “Agreement”) is entered into by and between Cellular Biomedicine Group, Inc., a Delaware corporation (the “Company”), and the undersigned investor (“Purchaser”).

 

NOW, THEREFORE, in consideration of the mutual covenants and other agreements contained in this Agreement the Company and the Purchaser hereby agree as follows:

 

1. Purchase of Common Stock.

 

(a) Subject to the terms and conditions of this Agreement, the Purchaser hereby subscribes for the number of shares of the Company’s Common Stock (as defined below) set forth in Section F. headed “Subscription Amount” of the related Statement of Investor Status marked Exhibit D and executed by the Purchaser (the “Shares”) at a purchase price of $38 per Share (such price per share, the “Purchase Price,” and the total amount to be paid for the Shares, the “Subscription Amount”).  Fractional shares of Common Stock will not be issued, and the number of shares of Common Stock to be issued in respect of a given Subscription Amount will be reduced to the nearest whole share.  The offering, purchase and sale of the Shares shall be referred to herein as the “Offering.”

 

(b) The Company is initially offering a total of up to 526,316 shares of Common Stock for aggregate proceeds of up to $20,000,000 (“Maximum Offering Amount”). The “Offering Expiration Date” shall be April 30, 2015, provided however, the Company may at its sole discretion elect to extend this date by up to an additional 60 calendar days.

 

2. Closing.

 

(a) On or prior to the applicable Closing Date (as defined below), Purchaser shall deliver or cause to be delivered the following in accordance with the subscription procedures described in Section 2(b) below:

 

(i) a completed and duly executed copy of this Agreement;

 

(ii) a completed and duly executed Statement of Investor Status attached as Exhibit A hereto (“Statement of Investor Status”);

 

(iii) an amount equal to the Subscription Amount, in the form of a wire transfer of immediately available funds to the Company, in accordance with the Company’s written instructions.

 

(b) The Purchaser shall deliver or cause to be delivered the closing deliveries described above to the Company by electronic mail (.pdf) to each of the following recipients:

 

	
(i)  

	
Tony Liu, Chief Financial Officer

Cellular Biomedicine Group, Inc.

 

  

  

  

 

	
(ii)  

	
Sarah Williams, Esq.

Ellenoff Grossman & Schole LLP at

 

You may also hand deliver your signed subscription documents to an officer of the Company, or mail printed and wet-ink signed versions of your subscription documents to:

 

Cellular Biomedicine Group, Inc.

530 University Avenue, #17

Palo Alto, CA 94301

Attn:  Tony Liu, Chief Financial Officer

Telephone:

 

(c) This Agreement sets forth various representations, warranties, covenants and agreements of the Company and the Purchaser, as the case may be, all of which shall be deemed made, and shall be effective without further action by the Company and the Purchaser, immediately upon the Company’s acceptance of the Purchaser’s subscription and shall thereupon be binding upon the Company and the Purchaser.  All representations, warranties, and covenants contained in this Agreement shall survive the closing.  Acceptance shall be evidenced only by execution of this Agreement by the Company on its signature page attached hereto and the Company shall have no obligation hereunder to the Purchaser until the Company shall have delivered to the Purchaser a fully executed copy of this Agreement.  Upon acceptance of the Purchaser’s subscription, the Company shall deliver to Purchaser, a certificate representing the Shares (which shall be issued in the name described in the Statement of Investor Status) on the applicable Closing Date. The Purchaser shall wire the Subscription Amount at closing, provided that the Purchaser is notified of the closing date with not less than three days notice by the Company.

 

(d) The purchase and sale of the Shares shall be consummated on or before April 30, 2015 (“Offering Expiration Date”); provided, however, that the Company reserves the right to extend the Offering Expiration Date for up to an additional 60 calendar days without notice. The Company may conduct one or more additional closings on dates it may select, for additional amounts aggregating up to the Maximum Offering Amount (the Initial Closing and each subsequent closing is referred to herein is referred to as a “Closing,” and the date of each respective Closing, a “Closing Date”).

 

3. Company Representations and Warranties.  The Company hereby represents and warrants that, as of the date of the Confidential Private Placement which accompanies this Agreement, a copy of which has been delivered to the Purchaser (the “Memorandum”), and as of the Closing Date applicable to the Purchaser:

 

(a) Organization and Business.  The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted.  The Company has two direct subsidiaries: (i) Cellular Biomedicine Group Ltd., a British Virgin Islands company, and (ii) EastBridge Investment Corp., a Delaware corporation, through which it owns and controls the entities (collectively, the “Company Entities”) described in the “Corporate Structure” diagram set forth in the Memorandum. The Company and each Company Entity is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which its ownership or use of property or the nature of the business conducted by it makes such qualification necessary except where the failure to be so qualified or in good standing would not have a Material Adverse Effect (as defined below).

 

  

  

  

 

(b) Capitalization.

 

(i) The authorized capital stock of the Company consists of 350,000,000 shares of which, 50,000,000 shares are designated as Preferred Stock, par value$0.001 per share (the “Preferred Stock”), none of which are issued and outstanding; and 300,000,000 shares are designated as Common Stock, par value $0.001 per share (the “Common Stock”), of which 10,995,235 shares are issued and outstanding.  Of this total number issued and outstanding, 95,407 shares are issued and outstanding under the Company’s 2009 Incentive Stock Option Plan (the “2009 Plan”), and 318,098-shares are issued and outstanding under the Company’s Amended and Restated 2011 Incentive Stock Option Plan (the “2011 Plan”).  The Company is authorized to issue up to 100,000 shares in connection with awards under the 2009 Plan, up to 780,000 shares in connection with awards under the 2011 Plan, up to 1,000,000 shares in connection with awards under the 2013 Plan and up to 1,200,000 shares in connection with awards under 2014 Plan.  A true and correct list of the Common Stock beneficially held by the Company’s officers, directors, and 5% shareholders (without taking into consideration the shares of Common Stock issued in connection with the Offering), is set forth under the heading “Security Ownership of Certain Beneficial Owners and Management” in the Memorandum.

 

(ii) All of the outstanding shares of Common Stock issued since the closing of the Company’s merger with Cellular Biomedicine Group Ltd. (BVI) on February 6, 2013 (the “Merger”) have been issued in compliance with all applicable federal and state securities laws and are duly authorized and have been validly issued, fully paid and non- assessable.

 

(iii) No shares of capital stock of the Company are subject to preemptive rights or any other similar rights of anyone or any mortgage, lien, title claim, assignment, encumbrance, security interest, adverse claim, contract of sale, restriction on use or transfer (other than restrictions on transfer under applicable state and federal securities laws or “blue sky” or other similar laws (collectively, the “Securities Laws”)) or other defect of title of any kind (each, a “Lien”) imposed through the actions or failure to act of the Company.  Except as disclosed in the Memorandum: (i) there are no outstanding options, warrants, scrip, rights to subscribe for, puts, calls, rights of first refusal, agreements, understandings, claims or other commitments or rights of any character whatsoever relating to, or securities or rights convertible into or exchangeable for any shares of capital stock of the Company, or arrangements by which the Company is or may become bound to issue additional shares of capital stock of the Company, (ii) there are no agreements or arrangements under which the Company is obligated to register the sale of any of its or their securities under the Securities Act of 1933, as amended (the “Securities Act”) and (iii) there are no anti-dilution or price adjustment provisions contained in any security issued by the Company (or in any agreement providing rights to security holders) that will be triggered by the issuance of the Shares.

 

  

  

  

 

(c) Authorization; Enforceability.  All corporate action on the part of the Company, its officers, directors and shareholders necessary for the authorization, execution and delivery of the Agreement, the performance of all obligations of the Company under the Agreement, and the authorization, issuance, sale and delivery of the Shares has been taken, and the Agreement constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights and general principles of equity that restrict the availability of equitable or legal remedies.

 

(d) Valid Issuance.  The Shares being acquired by the Purchaser hereunder, when issued, sold and delivered in accordance with the terms of this Agreement for the consideration expressed herein, will be duly and validly issued, fully paid, and non-assessable, and will be free of Liens other than restrictions on transfer under this Agreement.

 

(e) Litigation.  There is no action, suit, proceeding or investigation pending or, to the Company’s knowledge, currently threatened against the Company or any Company entity.  Neither the Company nor any Company Entity is a party or subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality.  There is no action, suit, proceeding or investigation by the Company or any Company Entity currently pending or that the Company or any Company Entity intends to initiate.

 

(f) No Conflict.  The execution, delivery and performance of this Agreement, and the other agreements entered into by the Company in connection with the Offering (the “Transaction Documents”) and the consummation by the Company of the transactions contemplated hereby and thereby will not: (i) conflict with or result in a violation of any provision of the charter or by-laws of the Company or any Company Entity or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company or any Company Entity is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations and regulations of any self-regulatory organizations to which the Company or any Company Entity or its of their securities are subject) applicable to the Company or by which any property or asset of the Company is bound or affected.  None of the Company or any Company Entity is in violation of its charter, bylaws, or other Organizational Documents. None of the Company or any Company Entity is in default (and no event has occurred which with notice or lapse of time or both could put the Company or such Company Entity in default) under, and none of the Company or any Company Entity has taken any action or failed to take any action that would give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement.  The business of the Company is not being conducted in violation of any law, rule, ordinance or regulation of any governmental entity, except for possible violations which would not, individually or in the aggregate, have a Material Adverse Effect.  Except for filings pursuant to Regulation D of the Securities Act, and applicable state securities laws, which have been made or will be made by the Company in the required time thereunder, the Company is not required to obtain any consent, authorization or order of, or make any filing or registration with, any court, governmental agency, regulatory agency, self regulatory organization or stock market or any third party in order for it to execute, deliver or perform any of its obligations under this Agreement or any Transaction Document in accordance with the terms hereof or thereof or to issue and sell the Shares in accordance with the terms hereof.

 

  

  

  

 

(g) Financial Statements of the Company.  A true and complete copy of the Company’s audited financial statements for the fiscal years ended December 31, 2013 and 2012 (the “Financial Statements”) are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, which is referenced in Appendix A of the Memorandum. The Financial Statements, in all material respects, fairly present the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein.

 

(h) Tax Matters.   The Company and each Company Entity has made, filed, or filed extension for, all federal, state and foreign income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject and has paid all taxes and other governmental assessments and charges, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply.  All such tax returns and reports filed on behalf of the Company or such Company Entity were complete and correct and were prepared in good faith without willful misrepresentation.  Except as disclosed in the Memorandum, there are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.  None of the Company or any Company Entity has executed a waiver with respect to the statute of limitations relating to the assessment or collection of any foreign, federal, state or local tax.

 

(i) Certain Transactions.  Except as disclosed in the Memorandum, there are no loans, leases, royalty agreements or other transactions between: (i) the Company or any of its respective customers or suppliers, and (ii) any officer, employee, consultant or director of the Company or any Person owning five percent (5%) or more of the ownership interests of the Company or any member of the immediate family of such officer, employee, consultant, director, stockholder or owner or any corporation or other entity controlled by such officer, employee, consultant, director, stockholder or owner, or a member of the immediate family of such officer, employee, consultant, director, stockholder or owner.

 

(j) No General Solicitation.  Neither the Company nor any Person participating on the Company’s behalf in the transactions contemplated hereby has conducted any “general solicitation,” as such term is defined in Regulation D promulgated under the Securities Act, with respect to any Shares offered in the Offering.

 

(k) No Integrated Offering.  Neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf, has directly or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require registration under the Securities Act of the issuance of the Shares.  The issuance of the Shares will not be integrated (as defined in Rule 502 of the Securities Act) with any other issuance of the Company’s securities (past, current or future) that would require registration under the Securities Act of the issuance of the Shares.

 

(l) Offering.  Subject to the accuracy of the Purchaser’s representations and warranties in Section 4 of this Agreement, and the accuracy of other purchasers’ representations and warranties in their respective subscription agreements, the offer, sale and issuance of the Shares in the Offering, constitute transactions exempt from or not subject to the registration requirements of Section 5 of the Securities Act and from the registration or qualification requirements of applicable state securities laws, and neither the Company nor any authorized agent acting on its behalf will take any action hereafter that would cause the loss of such exemption.

 

  

  

  

 

(m) SEC Documents; Financial Statements.  Since October 31, 2012, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by it with the Securities and Exchange Commission (the “SEC”) pursuant to the reporting requirements of the Securities Exchange Act of 1934 as amended (“Exchange Act”) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the “SEC Documents”).

 

(n) Absence of Certain Changes.  Except as disclosed in the Memorandum, since October 31, 2012, there has not been: (i) any material adverse change in the business, assets, liabilities, operations, or condition (financial or otherwise) or of the Company; (ii) any material damage or destruction to, or loss of, or sale of, any material asset of the Company or any Company Entity, outside of the ordinary course of business; (iii) any declaration or payment of any dividend or other distribution of assets of the Company or any Company Entity to its stockholders, or the adoption or consideration of any plan or arrangement with respect thereto; or (iv) any other event or condition of any character that could reasonably be expected to have a Material Adverse Effect.  None of the Company or any Company Entity has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company or any Company Entity have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so.

 

(o) Conduct of Business; Regulatory Permits.  None of the Company or any Company Entity is in violation of (a) any term of or in default under its Organizational Documents or (b) any Applicable Laws.  Since October 31, 2012, (i) the Common Stock has been listed or designated for quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by the SEC or the Principal Market and (iii) the Company has received no communication, written or oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from the Principal Market. The Company and each Company Entity possesses all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would not have, individually or in the aggregate, a Material Adverse Effect, and the Company has not received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit.

 

(p) Absence of Litigation.  Except as set forth in the Memorandum, there is no action, suit, proceeding, inquiry or investigation before or by any court or Governmental Authority pending or, to the knowledge of the Company, threatened against the Company, any Company Entity, or any officers or directors thereof. There is not in effect any order, judgment, decree, injunction or ruling of any Governmental Authority against, relating to or affecting the Company, any Company Entity, or any officer or director thereof, enjoining, barring, suspending, prohibiting or otherwise limiting the same from conducting or engaging in any aspect of the business of the Company.  None of the Company or any Company Entity is in default under any order, judgment, decree, injunction or ruling of any Governmental Authority, nor is the Company or any Company Entity subject to or a party to any order, judgment, decree or ruling arising out of any action, suit, arbitration or other proceeding under any Applicable Laws, respecting antitrust, monopoly, restraint of trade, unfair competition or similar matters.

 

  

  

  

 

(q) Intellectual Property Rights.  The Company owns or possesses adequate rights or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, original works, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor (“Intellectual Property Rights”) reasonably necessary to conduct its businesses as now conducted and as presently proposed to be conducted.  The Company has no knowledge of any infringement by the Company or any Company Entity of Intellectual Property Rights of any other Person.  There is no claim, action or proceeding being made or brought, or to the knowledge of the Company or any Company Entity, threatened against the Company, regarding Intellectual Property Rights.  The Company and each Company Entity has taken reasonable security measures to protect the secrecy, confidentiality and value of all of its Intellectual Property Rights.

 

(r) Definitions.  For purposes of this Agreement:

 

(i) “Applicable Laws” means all applicable provisions of all (i) constitutions, treaties, statutes, laws, rules, regulations and ordinances of any Governmental Authority and all common law duties, (ii) Consents of any Governmental Authority and (iii) orders, writs, decisions, rulings, judgments or decrees of any Governmental Authority binding upon, or applicable to, the Company, the Company Entities or Purchaser, as the case may be.

 

(ii) “Board” means the board of directors of the Company;

 

(iii) “Consents” means all consents, approvals, authorizations, waivers, permits, grants, franchises, licenses, findings of suitability, exemptions or orders of, or any registrations, certificates, qualifications, declarations or filings with, or any notices to, any Governmental Authority or other Person.

 

(iv) “Eligible Market” means The New York Stock Exchange, the NYSE Amex, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the OTC Bulletin Board, or OTCQB.

 

(v) “Governmental Authority” means any nation or government, and any state or political subdivision thereof, any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government (including the SEC and any court, tribunal or arbitrator(s) of competent jurisdiction, and any other stock exchange or self- regulatory organization, including the Nasdaq Capital market, OTC Bulletin Board, OTC Markets Inc. and the Pink OTC Markets, Inc.

 

(vi) “Material Adverse Effect” means any material adverse effect on the business, operations, assets (including intangible assets), liabilities (actual or contingent), financial condition, or prospects of the Company and the Company Entities, taken as a whole, or on the transactions contemplated hereby.

 

(vii) “Organizational Documents” means, collectively, with respect to any Person that is an entity, the articles of incorporation, certificate of incorporation, certificate of formation, articles of organization, bylaws, limited liability company agreement, operating agreement, partnership agreement and similar organizational documents of such Person, as applicable.

 

  

  

  

 

(viii) “Person” means any entity, corporation, company, association, joint venture, joint stock company, partnership, trust, organization, individual (including personal representatives, executors and heirs of a deceased individual), nation, state, government (including agencies, departments, bureaus, boards, divisions and instrumentalities thereof), trustee, receiver or liquidator, as well as any syndicate or group that would be deemed to be a Person under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended.

 

(ix) “Principal Market” means the Eligible Market on which the Common Stock is primarily listed on or quoted for trading, which, as of the date of this Agreement and the Closing Date, shall be the Nasdaq Capital Market.

 

4. Purchaser Acknowledgements and Representations.  In connection with the purchase of the Shares, the Purchaser represents and warrants as of the Closing Date applicable to the Purchaser and/or acknowledges, to the Company, the following:

 

(a) Acceptance.  The Company may accept or reject this Agreement and the number of Shares subscribed for hereunder, in whole or in part, in its sole and absolute discretion.  The Company has no obligation to issue any of the Shares to any person who is a resident of a jurisdiction in which the issuance of the Shares would constitute a violation of the Securities Laws.

 

(b) Irrevocability. This Agreement is and shall be irrevocable, except that the Purchaser shall have no obligations hereunder to the extent that this Agreement is rejected by the Company. The Purchaser has the right to demand repayment of Subscription Amount if subscription is not confirmed within 30 days after all application materials have been received by the Company.

 

(c) Binding.  This Agreement constitutes a legal, valid and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except to the extent limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights and general principles of equity that restrict the availability of equitable or legal remedies.

 

(d) No Governmental Review.  No federal or state agency has made any finding or determination as to the fairness of the Offering for investment, or any recommendation or endorsement of the Shares. The Purchaser understands that neither the SEC nor any state securities commission has approved or disapproved of the Shares or passed upon or endorsed the merits of the Offering and has not been reviewed by any federal, state or other regulatory authority.

 

(e) Voting Power.  The Shares issued to the Purchaser are entitled to one vote per Share.  The Shares do not entitle the Purchaser to preemptive rights.

 

  

  

  

 

(f) Professional Advice; Investment Experience.  The Company has made available to the Purchaser, or to the Purchaser’s attorney, accountant or representative, all documents that the Purchaser has requested, and the Purchaser has requested all documents and other information that the Purchaser has deemed necessary to consider respecting an investment in the Company.  The Company has provided answers to all questions concerning the Offering and an investment in the Company.  The Purchaser has carefully considered and has, to the extent the Purchaser believes necessary, discussed with the Purchaser’s professional technical, legal, tax and financial advisers and his/her/its representative (if any) the suitability of an investment in the Company for the Purchaser’s particular tax and financial situation.  All information the Purchaser has provided to the Company concerning the Purchaser and the Purchaser’s financial position is, to the Purchaser’s knowledge, correct and complete as of the date set forth below, and if there should be any material adverse change in such information prior to the acceptance of this Agreement by the Company, the Purchaser will immediately provide such information to the Company.  The Purchaser, either alone or together with its advisors, has such knowledge, skill, and experience in technical, business, financial, and investment matters so that he/she/it is capable of evaluating the merits and risks of an investment in the Shares.  To the extent necessary, the Purchaser has retained, at his/her/its own expense, and relied upon, appropriate professional advice regarding the technical, investment, tax, and legal merits and consequences of this Agreement and owning the Shares. The Purchaser is not relying on the Company, or any of its respective employees or agents with respect to the legal, tax, economic and related considerations of an investment in any of the Shares and the Purchaser has relied on the advice of, or has consulted with, only its own advisors.

 

(g) Use of Proceeds. The Purchaser acknowledges and understands that the proceeds from the sale of the Shares will be used as described in the Memorandum.

 

(h) No Minimum Offering Amount. The Purchaser understands that there is no minimum amount which must be raised before the Company holds an initial closing of this Offering and that the Company will not have enough money to implement its business plan unless it raises a substantial percentage of the Offering amount.

 

(i) Brokers and Finders.  Other than participating finders with respect to the Company for purposes of this transaction, no Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim against or upon the Company or the Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Purchaser.  The Purchaser acknowledges that it is purchasing the Shares directly from the Company and not from the participating finder.  The Purchaser further acknowledges and understands that in consideration for its services for the Offering, the participating finder shall receive the finder fees disclosed in the Memorandum.

 

(j) Investment Purpose.  The Purchaser is purchasing the Shares for investment for his, her or its own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act.  The Purchaser further represents that he/she/it does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares.  If the Purchaser is an entity, the Purchaser represents that it has not been formed for the specific purpose of acquiring the Shares.  The Purchaser acknowledges that an investment in the Shares is a high-risk, speculative investment.

 

  

  

  

 

(k) Reliance on Exemptions.  The Purchaser understands that the Shares are being offered and sold to it in reliance upon specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire the Shares.

 

(l) Restricted Securities.  The Purchaser understands that the Shares are “restricted securities” under applicable Securities Laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available.  The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares for resale.

 

The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and requirements relating to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation and may not be able to satisfy.

 

(m) Professional Advice.  The Company has not received from its legal counsel, accountants or professional advisors any independent valuation of the Company or any of its equity securities, or any opinion as to the fairness of the terms of the Offering or the adequacy of disclosure of materials pertaining to the Company or the Offering.

 

(n) Risk of Loss.  The Purchaser has adequate net worth and means of providing for his/her/its current needs and personal contingencies to sustain a complete loss of the investment in the Company at the time of investment, and the Purchaser has no need for liquidity in the investment in the Shares.  The Purchaser understands that an investment in the Shares is highly risky and that he/she/it could suffer a complete loss of his/her/its investment.

 

(o) Information.  The Purchaser understands that any plans, estimates and projections, provided by or on behalf of the Company, involve significant elements of subjective judgment and analysis that may or may not be correct; that there can be no assurance that such plans, projections or goals will be attained; and that any such plans, projections and estimates should not be relied upon as a promise or representation of the future performance of the Company.  The Purchaser acknowledges that neither the Company nor anyone acting on the Company’s behalf makes any representation or warranty, express or implied, as to the accuracy or correctness of any such plans, estimates and projections, and there are no assurances that such plans, estimates and projections will be achieved.  The Purchaser understands that the Company’s technology is new and untested and has not been commercialized and that there is no guarantee that the technology will be successfully commercialized.  The Purchaser understands that, because the technology is new and product or therapeutic candidates have not been commercialized, all the risks associated with the technology are not now known.

 

  

  

  

 

(p) Exclusive Reliance on Private Placement Memorandum.  Before investing in the Offering, the Purchaser has fully reviewed the Memorandum, and has been given the opportunity to ask questions of the Company about the technology and the Company’s business and the Purchaser has received answers to those questions.  In making an investment decision, the Purchaser has relied solely upon the information set forth and provided in the Memorandum. The Purchaser understands and acknowledges that the Company has not authorized any translated versions of the Memorandum, and for all purposes the original Company-issued English version of the Memorandum shall be the controlling version.

 

(q) Authorization; Enforcement.  Each Transaction Document to which a Purchaser is a party: (i) has been duly and validly authorized, (ii) has been duly executed and delivered on behalf of the Purchaser, and (iii) will constitute, upon execution and delivery by the Purchaser thereof and the Company, the valid and binding agreements of the Purchaser enforceable in accordance with their terms, except to the extent limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights and general principles of equity that restrict the availability of equitable or legal remedies.

 

(r) Accredited Investors.  The Purchaser is an “accredited investor” as that term is defined in Rule 501(a) under Regulation D promulgated pursuant to the Securities Act, and the statements and representations in the related Statement of Investor Status marked as Exhibit D executed by the Purchaser;

 

(s) Residency.  If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth in the related Statement of Investor Status marked as Exhibit D executed by the Purchaser; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which its principal place of business is located is identified in the address or addresses of the Purchaser set forth in the related Statement of Investor Status marked Exhibit D executed by the Purchaser.

 

(t) Communication of Offer. The Purchaser was contacted solely by the Company or an employee thereof with respect to a potential investment in the Shares.  The Purchaser is not purchasing the Shares as a result of any “general solicitation” or “general advertising,” as such terms are defined in Regulation D of the Securities Act, which includes, but is not limited to, any advertisement, article, notice or other communication regarding the Shares published in any newspaper, magazine or similar media or on the internet or broadcast over television, radio or the internet or presented at any seminar or any other general solicitation or general advertisement.  The Purchaser acknowledges no placement agent solicited this transaction.

 

(u) No Conflicts.  The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the Purchaser of the transactions contemplated hereby will not (i) result in a violation of the Organizational Documents of the Purchaser (if the Purchaser is an entity), (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Purchaser is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to the Purchaser.

 

  

  

  

 

(v) Organization.  If the Purchaser is an entity, it is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the applicable Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.  If the Purchaser is an entity, the execution, delivery and performance by the Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate action or, if the Purchaser is not a corporation, such partnership, limited liability company or other applicable like action, on the part of the Purchaser.

 

(w) No Other Representations.  Other than the representations and warranties contained herein, the Purchaser has not received and is not relying on any representation, warranties or assurances as to the Company, its business or its prospects from the Company or any other Person or entity. The Purchaser has not been furnished with any oral representation or oral information in connection with the offering of the Shares that is not contained in, or is in any way contrary to or inconsistent with, statements made in this Agreement.

 

5. Covenants.  In addition to the other agreements and covenants set forth herein, the applicable parties hereto covenant as follows:

 

(a) Use of Proceeds.  The Company will use the net proceeds from the Offering for working capital and general corporate purposes which are described in the Memorandum.

 

(b) Company Registration.  The Company will use commercially reasonable efforts to prepare and file a registration statement with the SEC on Form S-1 covering the registration of the Shares within 30 days after the completion of this Agreement, and to cause such registration statement to be declared effective by the SEC.

 

(c) Piggyback Registration Rights.  The Company agrees that if, after the date hereof, the Board shall authorize the filing of a registration statement under the Securities Act (other than a registration statement (i) filed in connection with an offering of securities to employees or directors of the Company pursuant to any employee stock option or other benefit plan, (ii) filed on Form S-4 or S-8 or any successor to such forms, (iii) for an exchange offer or offering of securities solely to the Company’s existing security holders, (iv)  for a dividend reinvestment plan, or (v) solely in connection with a merger, share capital exchange, asset acquisition, share purchase, reorganization, amalgamation, subsequent liquidation, or other similar business transaction that results in all of the Company’s shareholders having the right to exchange their common stock for cash, securities or other property of a non-capital raising bona fide business transaction) in connection with the proposed offer of any of its securities by it or any corporation with which it may combine or merge subsequent to the Offering, the Company shall: (A) promptly notify the Purchaser that such registration statement will be filed and that the Shares purchased pursuant to this Agreement and then held by the Purchaser (hereinafter the “Registrable Securities”) will be included in such registration statement at the Purchaser’s request; (B) cause such registration statement to cover all of the Registrable Securities issued to the Purchaser for which the Purchaser requests inclusion; (C) use reasonable best efforts to cause such registration statement to become effective as soon as practicable; and (D) take all other reasonable action necessary under any federal or state law or regulation of any Governmental Authority to permit all such Registrable Securities that have been issued to such Purchaser to be sold or otherwise disposed of, and will maintain such compliance with each such federal and state law and regulation of any Governmental Authority for the period necessary for the Purchaser to promptly effect the proposed sale or other disposition, but no later than the date that, assuming compliance with all of the requirements of Rule 144 promulgated under the Securities Act, the Purchaser would be entitled to sell all the Registrable Securities pursuant to Rule 144 without limitation.  If the Purchaser desires to include in such registration statement all or any part of the Registrable Securities held by him/her/it, he/she/it shall, within twenty (20) days after the above-described notice from the Company, so notify the Company in writing. Such notice shall state the intended method of disposition of the Registrable Securities by the Purchaser.  If the Purchaser decides not to include all of his/her/its Registrable Securities in any registration statement thereafter filed by the Company, the Purchaser shall nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein.  As used in this Section 5, the term “Shares” refers to the purchased Shares, all securities received in replacement of or in connection with the Shares pursuant to stock dividends or splits, all securities received in replacement of the Shares in a recapitalization, merger, reorganization, exchange or the like, and all new, substituted or additional securities or other properties to which the Purchaser is entitled by reason of the Purchaser’s ownership of the Shares.

 

  

  

  

 

(d) Underwriting Requirements.  In connection with any registration statement subject to Section 5(d) involving an underwritten offering of shares of the Company’s capital stock, the Company shall not be required to include any of the Registrable Securities in such underwriting unless the Purchaser accepts the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the Company in its sole discretion determines will not jeopardize the success of the offering by the Company.  If the total number of securities to be included in such offering (the “Requested Securities”) exceeds the number of securities to be sold (other than by the Company) that the Company in its reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of the Requested Securities, which the Company in its sole discretion determines will not jeopardize the success of the offering.  If the Company determines that less than all of the Requested Securities requested to be registered can be included in such offering, then the securities to be registered that are included in such offering shall be allocated among the holders of the securities (the “Holders”) in proportion (as nearly as practicable to) the number of Requested Securities owned by the Holders.  To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest 10 shares.  Notwithstanding the foregoing, in no event shall the number of Requested Securities included in the offering be reduced below thirty percent (30%) of the total number of securities included in such offering, unless such offering is the initial public offering of the Company, in which case the Holders may be excluded further if the Company makes the determination described above and no other shareholder’s securities are included in such offering.  For purposes of the provision in this Section 5(e) concerning apportionment, for any Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members, stockholders, and affiliates of such Holder, or the estates and immediate family members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing persons, shall be deemed to be a single “Holder,” and any pro rata reduction with respect to such “Holder” shall be based upon the aggregate number of Requested Securities owned by all persons included in such “Holder,” as defined in this sentence.

 

  

  

  

 

(e) Abandonment or Delay of Registration.  Notwithstanding any other provision of this Section 4, the Company may not abandon or delay any registration commenced by the Company unless such registration is no longer feasible.  In the event of such an abandonment by the Company, the Company shall not be required to continue registration of the Registrable Securities requested by the Purchaser for inclusion, the Purchaser shall retain the right to request inclusion of the Registrable Securities as set forth above and the withdrawn registration shall not be deemed to be a registration request for the purposes of this Section 4.

 

(f) Expenses.  The Holders shall be responsible for all underwriting discounts and selling commissions with respect to his/her/its Registrable Securities being sold. The Company will pay all other expenses incurred by it associated with each registration, including, without limitation, all filing and printing fees, the Company’s counsel and accounting fees and expenses, costs associated with clearing the Registrable Securities for sale under applicable Securities Laws, and listing fees.

 

(g) Qualification in States.  Prior to any public offering of Registrable Securities, the Company will use commercially reasonable efforts to register or qualify or cooperate with the Purchaser and applicable counsel to the holders of securities being registered in connection with the registration or qualification of the Registrable Securities for offer and sale under the securities or blue sky laws of such jurisdictions requested by the Purchaser as shall be reasonably appropriate in the opinion of the Company and do any and all other commercially reasonable acts or things necessary or advisable to enable the distribution in such jurisdictions of the Registrable Securities covered by the registration statement; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (i) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 5(h), (ii) subject itself to general taxation in any jurisdiction where it would not otherwise be so subject but for this Section 5(h), or (iii) file a general consent to service of process in any such jurisdiction; and provided further that (notwithstanding anything in this Agreement to the contrary with respect to the bearing of expenses) if any jurisdiction in which any of such Registrable Securities shall be qualified shall require that expenses incurred in connection with the qualification therein of any such Registrable Securities be borne by the selling holders of securities to be registered, then the such selling holders shall, to the extent required by such jurisdiction, pay their pro rata share of such qualification expenses.

 

(h) Effectiveness.  Subject to the terms and conditions of this Agreement, the Company shall use reasonable best efforts to have the registration statement filed pursuant to this Section 9 declared effective.  The Company shall notify the Purchaser by facsimile or e- mail as promptly as practicable after the registration statement is declared effective and shall simultaneously provide the Purchaser with copies of any related prospectus to be used in connection with the sale or other disposition of the Registrable Securities covered thereby.

 

(i) Allowed Delay.  The Company may delay the disclosure of material non- public information concerning the Company by suspending the use of any prospectus included in any registration statement contemplated hereunder required to contain such information, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company (an “Allowed Delay”); provided, that the Company shall promptly (a) notify the Purchaser in writing of the existence of (but in no event, without obtaining an agreement from the Purchaser agreeing to keep the information confidential, shall the Company disclose to the Purchaser any of the facts or circumstances regarding) material non-public information giving rise to an Allowed Delay, (b) advise the Purchaser in writing to cease all sales under the registration statement until the end of the Allowed Delay and (c) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.

 

  

  

  

 

6. Restrictive Legends and Stop-Transfer Orders.

 

(a) Legends. The certificate or certificates representing the Shares shall bear the following legends (as well as any legends required by applicable state corporate law and the Securities Laws), as appropriate and in the discretion of the Company:

 

	
(i)  

	
THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.  NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL (OR OTHER EVIDENCE) IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

 

	
(ii)  

	
“THESE SECURITIES ARE BEING OFFERED TO INVESTORS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“THE SECURITIES ACT”)) AND WITHOUT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT.”

 

	
(iii)  

	
HEDGING TRANSACTIONS INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE CONDUCTED, DIRECTLY OR INDIRECTLY, UNLESS IN COMPLIANCE WITH THE SECURITIES ACT OF 1933, AS AMENDED.  THE SECURITIES MAY NOT BE OFFERED, SOLD OR TRANSFERRED TO A U.S. PERSON, OR FOR THE ACCOUNT OR BENEFIT OF A U.S. PERSON, OR INTO THE UNITED STATES EXCEPT PURSUANT TO A REGISTRATION STATEMENT, OR A VALID EXEMPTION FROM REGISTRATION BASED ON AN OPINION OF COUNSEL APPROVED BY THE ISSUER.

 

	
(iv)  

	
 Any legend required to be placed thereon by any appropriate securities commissioner.

 

  

  

  

 

(b) Stop-Transfer Notices.  The Purchaser agrees that, to ensure compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records.

 

(c) Refusal to Transfer.  The Company shall not be required (i) to transfer on its books any Shares if such transfer is in violation of any applicable Securities Laws, or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred.

 

(d) Removal of Restrictive Legend. The Purchaser agrees that the removal of the restrictive legend from certificates representing Shares as set forth in this Section is predicated upon the Company’s reliance that the Purchaser will sell any Shares pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom.

 

7. Conditions to Closing.

 

(a) Conditions to the Company’s Obligation to Sell.  The obligation of the Company hereunder to issue and sell the Shares to the Purchaser is subject to the satisfaction, at or before the applicable Closing Date of each of the following conditions, provided that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

 

(i) The Purchaser shall have complied with Section 2(a);

 

(ii) The representations and warranties of the Purchaser shall be true and correct in all material respects; and

 

(iii) No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or Governmental Authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

(b) Conditions to Each Purchaser’s Obligation to Purchase.  The obligation of the Purchaser hereunder to purchase the Shares is subject to the satisfaction, at or before the applicable Closing Date of each of the following conditions, provided that these conditions are for the Purchaser’s sole benefit and may be waived by the Purchaser at any time in his/her/its sole discretion:

 

(i) The Company shall have complied with Section 2(c);

 

(ii) The representations and warranties of the Company shall be true and correct as of the applicable Closing Date, and the Company shall have performed, satisfied and complied with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the applicable Closing Date. The Purchaser shall have received a certificate or certificates, executed by the chief executive officer of the Company, dated as of the applicable Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Purchaser including, but not limited to certificates with respect to the Company’s charter, by-laws and Board resolutions relating to the transactions contemplated hereby;

 

  

  

  

 

(iii) No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement; and

 

(iv) No event shall have occurred which would reasonably be expected to have a Material Adverse Effect.

 

8. Miscellaneous.

 

(a) Governing Law.  This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of New York, without giving effect to principles of conflicts of law, and any applicable U.S. federal laws.

 

(b) Consent to Jurisdiction and Venue.  Any suit, legal action or similar proceeding arising out of or in connection with this agreement shall be brought exclusively in the courts sitting in New York City or in the courts of the United States for the Southern District of New York sitting in New York City.  The Purchaser consents, for itself and in respect of its property, to the exclusive jurisdiction of such courts and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.

 

(c) Waiver of Jury Trial.  To the fullest extent permitted by applicable law, each party hereby knowingly, intentionally and voluntarily expressly waives any right to trial by jury of any claim, demand, action or cause of action arising out of or in connection with this Agreement, the Transaction Documents, or the transactions related thereto, in each case whether now existing or hereafter arising.

 

(d) Entire Agreement; Enforcement of Rights.  This Agreement and the Transaction Documents, together with the exhibits and schedules attached thereto, set forth the entire agreement and understanding of the parties relating to the subject matter herein and supersedes any and all prior agreements or discussions between them, including any term sheet, letter of intent or other document executed by the parties prior to the date hereof relating to such subject matter.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.

 

(e) Severability.  If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. If the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms.

 

  

  

  

 

(f) Construction.  This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly, this Agreement shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any one of the parties hereto.

 

(g) Notices.  Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient when delivered personally or sent by fax or 48 hours after being deposited in the U.S. mail, as certified or registered mail, with postage prepaid, and addressed to the party to be notified at such party’s address or fax number or as subsequently modified by written notice.

 

(h) Counterparts.  This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same instrument.  In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.  Any party delivering an executed counterpart of this Agreement by facsimile or other electronic method of transmission also shall deliver an original executed counterpart of this Agreement, but the failure to deliver an original executed counterpart shall not affect the validity, enforceability, and binding effect of this Agreement.  This Agreement shall become effective upon the execution of a counterpart thereof by each of the parties.

 

(i) Successors and Assigns.  The rights and benefits of this Agreement shall inure to the benefit of, and be enforceable by the Company’s successors and assigns.  The covenants and obligations of the Company hereunder, including without limitation the registration obligations described in Section 5, shall inure to the benefit of, and be enforceable by the Purchaser against the Company, its successors and assigns, including any entity into which the Company is merged.  The rights and obligations of Purchaser under this Agreement may only be assigned with the prior written consent of the Company.

 

(j) Third Party Beneficiary.  This Agreement is intended for the benefit of the undersigned parties and their respective permitted successors and assigns, and the Company, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

(k) Further Assurances.  Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(l) Expenses.  Each party shall pay all costs and expenses that it incurs with respect to the negotiation, execution, delivery and performance of the Agreement.

 

  

  

  

 

(m) Survival.  The representations, warranties, covenants and agreements made herein shall survive the closing of the transaction contemplated hereby.  All statements as to factual matters contained in any certificate or other instrument delivered by or on behalf of the Company pursuant hereto in connection with the transactions contemplated hereby shall be deemed to be representations and warranties by the Company hereunder solely as of the date of such certificate or instrument.  The representations, warranties, covenants and obligations of the Company, and the rights and remedies that may be exercised by the Purchaser, shall not be limited or otherwise affected by or as a result of any information furnished to, or any investigation made by or knowledge of, any of the Purchaser or any of their representatives. The Purchaser shall be responsible only for its own representations, warranties, agreements and covenants hereunder.

 

(n) Attorneys’ Fees.  In the event that any suit or action is instituted under or in relation to this Agreement, including without limitation to enforce any provision in this Agreement, the prevailing party in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and accountants, which shall include, without limitation, all fees, costs and expenses of appeals.

 

(o) Remedies.  All remedies afforded to any party by law or contract, shall be cumulative and not alternative and are in addition to all other rights and remedies a party may have, including any right to equitable relief and any right to sue for damages as a result of a breach of this Agreement.  Without limiting the foregoing, no exercise of a remedy shall be deemed an election excluding any other remedy.

 

(p) Publicity.  Each party will consult with the other before issuing, and provide each other the opportunity to review, comment upon and concur with and use reasonable efforts to agree on, any press release or other public statement with respect to the transactions contemplated by this Agreement, and shall not issue any such press release or make such other public announcement prior to such consultation, except as either party may determine is required under Applicable Laws.

 

 

[Remainder of Page Intentionally Left Blank]

  

  

  

 

IN WITNESS WHEREOF, the Purchaser has executed this Agreement as of

 

, 2015.

 

	
9. PURCHASER (if individual):

 

	
10. PURCHASER (if entity):

 

	
11. 

 

___________________________________

Signature

	
12. 

 

___________________________________

Name of Entity

	
13. 

 

___________________________________

Name (type of print)

	
14. 

 

By: ________________________________

 

	
15. 

 

 

	
16. 

 

Name: _____________________________

	
17. 

 

___________________________________

Signature of Co-Signer (if any)

	
18. 

 

Its: ________________________________

 

	
19. 

 

___________________________________

Name of Co-Signer (type of print)

	
20. 

 

 

AGREED AND ACCEPTED as of _______________________, 2015.

 

 

CELLULAR BIOMEDICINE GROUP, INC.

 

By:

 

 

Wei (William) Cao

Chief Executive OfficeExhibit 10.38

 

	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 1

 

LEASE AGREEMENT

 

THIS LEASE AGREEMENT is
made as of this 30th day of December, 2014, between ARE-East River Science Park, LLC a Delaware limited liability company (“Landlord”),
and Immune Pharmaceuticals, Inc., a Delaware corporation (“Tenant”).

 

BASIC LEASE PROVISIONS

 

		Address:	430 East 29th Street, New York, New York, 10016.

 

		Premises:	That portion of the Project, known as Suite 940, containing 2,175 rentable square feet (as determined by Landlord and accepted
for all purposes by Tenant), on the 9th floor in the Building in the Science Hotel® (the “Premises”), in
the 418,639 rentable square foot West Tower (the “Building”) of the of the Alexandria CenterTM for Life
Science – New York City (“Alexandria Center”), as shown on Exhibit A.

 

		Shared Work Area:	That portion of the Building on the ninth floor, as shown
on Exhibit N.

 

		Project:	The Alexandria Center, including the Land, all buildings
(including the Building) and other improvements located (or to be located) thereon and appurtenances thereto.

 

		Base Rent:	$16,675.00 per month ($200,100.00 per annum), which Base
Rent amount shall include all in-suite utilities for Suite 940.

 

		Building:	The West Tower of the Project. 

 

		Building’s Share:	The proportionate share of the Project attributed to the
Building, which shall be the ratio of the total rentable square feet then in the Building to the total rentable square feet then
in the Project, as determined by Landlord from time to time (which proportionate share currently is determined by Owner to be
57.53%). Landlord agrees to notify Tenant of changes in the Building’s Share.

 

		Land:	That
                                         certain real property more particularly described on Exhibit B.

 

		Tenant’s Share:	0.5195%.

 

		Tenant’s Share (SWA):	7.0153%

 

		Security Deposit:	Unconditional and irrevocable letter of credit, as more
particularly described on Exhibit J attached hereto, naming Landlord as beneficiary, to be delivered by Tenant on the date
hereof, in form, and from a bank, acceptable to Landlord, in the amount of $100,050.00.

 

		Target Commencement Date:	February 1, 2015.

 

		Rent Commencement Date:	3 months following the Commencement Date.

 

		Rent Adjustment Percentage:	3.5%

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 2

    

 

		Base Term:	Beginning on the Commencement Date and ending 63 months
from the first day of the first full calendar month of the Term (as defined in Section 2) hereof.

 

		Permitted Use:	Research and development laboratory, related office and
other related uses consistent with the character of the Project and otherwise in compliance with the provisions of Section
8 hereof.

 

	Address for Rent Payment via Regular Mail:	Address for Rent Payment via Overnight
    Courier:
	
        P.O. Box 975383

        Dallas, TX 75397-5383

         

        Wire/ACH Payment Information:
	JP Morgan Chase

Alexandria Real Estate Equities

Lockbox 975383 TX1-0006

14800 Frye Road

Fort Worth, TX 76155

 

	Bank Name:	JPMorgan Chase Bank NA	 
	Bank Address:	201 N. Central Ave.	 
	 	Phoenix, AZ 85004	 
	Account Name:	ARE-East River, LLC	 
	Account Number:		 
	Wire ABA Number:		 
	ACH ABA Number:		 

 

	Tenant’s Notice Address:	Landlord’s Notice Address:
	1 Broadway, 14th Floor

Cambridge, MA 02142

Attention: Dr. Daniel Teper, CEO	385 East Colorado Blvd., Suite 299

Pasadena, CA 91101

Attention: Corporate Secretary

 

The following Exhibits and Addenda are attached hereto and incorporated
herein by this reference:

 

	[   ]  EXHIBIT A - PREMISES DESCRIPTION	[   ]  EXHIBIT B – LEGAL DESCRIPTION OF PROJECT
	[   ]  EXHIBIT C - [INTENTIONALLY OMITTED]	[   ]  EXHIBIT D – ACKNOWLEDGEMENT OF COMMENCEMENT DATE
	[   ]  EXHIBIT E - RULES AND REGULATIONS	[   ]  EXHIBIT F - TENANT’S PERSONAL PROPERTY
	[   ]  EXHIBIT G – [INTENTIONALLY OMITTED]	[   ]  EXHIBIT H – [INTENTIONALLY OMITTED]
	[   ]  EXHIBIT I – [INTENTIONALLY OMITTED]	[   ]  EXHIBIT J – FORM OF LETTER OF CREDIT
	[   ]  EXHIBIT K – [INTENTIONALLY OMITTED]	[   ]  EXHIBIT L – OPEN SPACE DESCRIPTION
	[   ]  EXHIBIT M – SUPERIOR INSTRUMENT EXCERPTS	[   ]  EXHIBIT N - SHARED WORK AREA
	[   ]  EXHIBIT O - SHARED WORK SYSTEMS	 

 

1.          Lease
of Premises. Upon and subject to all of the terms and conditions hereof, Landlord hereby leases the Premises to Tenant and
Tenant hereby leases the Premises from Landlord. Tenant shall have a license, on a non-exclusive basis in common with other tenants
and users of the Project, to use all of the Building’s public hallways, lobbies, fitness center, corridors and passages and
the Building’s public stairways as “Common Areas” from time to time, in accordance with the Rules and
Regulations applicable thereto and all Legal Requirements; but “Common Areas” shall not include any area within
the Premises or any other leased or leasable area of the Project, and such access and use shall be subject to the terms of the
Superior Instruments (as defined in Section 28). Landlord reserves the right to modify, from time to time, the Project,
the Building, the Open Space and the Common Areas, provided that such modifications do not materially adversely affect Tenant's
use of the Premises for the Permitted Use. No vault or cellar is leased hereunder, anything to the contrary indicated elsewhere
in this Lease notwithstanding. As used herein, the term “Open Space” shall mean the portion of the Project that
will be subject to a permanent and perpetual public use and access easement, of a location and size substantially as shown on Exhibit
L, or otherwise in accordance with the Declaration (Corrective) dated December 29, 2006 by ARE – East River Park, LLC,
recorded February 20, 2007 at CRFN 2007000094401, as the same may be modified from time to time.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 3

    

 

2.          Delivery;
Acceptance of Premises; Commencement Date. Landlord shall use commercially reasonable efforts to deliver the Premises and the
ninth floor portion of the Shared Work Area to Tenant in accordance with the terms of this Lease on or before the Target Commencement
Date ("Delivery" or "Deliver"). If Landlord fails to timely Deliver the Premises and the ninth
floor portion of the Shared Work Area, Landlord shall not be liable to Tenant for any loss or damage resulting therefrom, and this
Lease shall not be void or voidable or subject to termination except as provided herein. If Landlord does not Deliver the Premises
and the ninth floor portion of the Shared Work Area within 60 days of the Target Commencement Date for any reason other than Force
Majeure delays and Tenant delays, this Lease may be terminated by Landlord or Tenant by written notice to the other, and
if so terminated by either: (a) the Security Deposit, or any balance thereof (i.e., after deducting therefrom all amounts to which
Landlord is entitled under the provisions of this Lease), shall be returned to Tenant, and (b) neither Landlord nor Tenant shall
have any further rights, duties or obligations under this Lease, except with respect to provisions which expressly survive termination
of this Lease. As used herein, the term "Force Majeure" shall have the meaning set forth for such term
in Section 35. If neither Landlord nor Tenant elects to void this Lease within 5 business days of the lapse of such 60 day
period, such right to void this Lease shall be waived and this Lease shall remain in full force and effect. Tenant expressly waives
any right to rescind this Lease under Section 223-a of the New York Real Property Law or under any present or future statute of
similar import then in force and further expressly waives the right to recover any damages, direct or indirect, which may result
from Landlord’s failure to deliver possession of the Premises by the Target Commencement Date or to grant access to certain
portions of the Premises prior to the Target Commencement Date as permitted hereunder. Tenant agrees that the provisions of this
Section 2 are intended to constitute “an express provision to the contrary” within the meaning of said Section
223-a.

 

(a)         The
“Commencement Date” shall be the earliest of: (i) the date Landlord Delivers the Premises to Tenant; (ii) the
date Landlord could have Delivered the Premises but for Tenant delays; and (iii) the date Tenant conducts any business in the Premises
or any part thereof. Upon request of Landlord, Tenant shall execute and deliver a written acknowledgment of the Commencement Date,
the Rent Commencement Date and the expiration date of the Term when such are established in the form of the “Acknowledgement
of Commencement Date” attached to this Lease as Exhibit D; provided, however, Tenant’s failure
to execute and deliver such acknowledgment shall not affect Landlord’s rights hereunder. The “Term” of
this Lease shall be the Base Term, as defined above in the Basic Lease Provisions hereof.

 

(b)         Upon
delivery of the Premises to Tenant: (i) Tenant shall accept the Premises in their "AS-IS” in their condition as of the
Commencement Date; (ii) Landlord shall have no obligation for any defects in the Premises, to perform any work or make any installations
in order to prepare the Premises for Tenant's occupancy; and (iii) Tenant's taking possession of the Premises shall be conclusive
evidence that Tenant accepts the Premises and that the Premises were in good condition at the time possession was taken. Any occupancy
of the Premises by Tenant before the-Commencement Date shall be subject to all of the terms and conditions of this Lease, including
the obligation to pay Rent.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 4

    

 

(c)         Tenant
agrees and acknowledges that neither Landlord nor any agent of Landlord has made any representation or warranty with respect to
the condition of all or any portion of the Premises, the Building or the Project, and/or the suitability of the Premises, the Building
or the Project for the conduct of Tenant’s business, and Tenant waives any implied warranty that the Premises, the Building
or the Project are suitable for the Permitted Use. No rights, easements or licenses are acquired by Tenant by implication or otherwise
except as expressly set forth in this Lease. This Lease constitutes the complete agreement of Landlord and Tenant with respect
to the subject matter hereof and supersedes any and all prior representations, inducements, promises, agreements, understandings
and negotiations which are not contained herein. Landlord in executing this Lease does so in reliance upon Tenant’s representations,
warranties, acknowledgments and agreements contained herein.

 

3.          Rent.

 

(a)         Base
Rent. The first month’s Base Rent and the Security Deposit shall be due and payable on delivery of an executed copy of
this Lease to Landlord. Tenant shall pay to Landlord in advance, without demand, abatement, deduction or set-off, monthly installments
of Base Rent on or before the first day of each calendar month during the Term hereof after the Rent Commencement Date, in lawful
money of the United States of America, at the office of Landlord for payment of Rent set forth above, or to such other person or
at such other place as Landlord may from time to time designate in writing. Payments of Base Rent for any fractional calendar month
shall be prorated. The obligation of Tenant to pay Base Rent and other sums to Landlord and the obligations of Landlord under this
Lease are independent obligations. Tenant shall have no right at any time to abate, reduce, or set-off any Rent (as defined in
Section 5(c)) due hereunder except for any abatement as may be expressly provided in this Lease.

 

(b)         Additional
Rent. In addition to Base Rent, Tenant agrees to pay to Landlord as additional rent (“Additional Rent”):
(i) Tenant’s Share of “Operating Expenses” (as defined in Section 5(a)), (ii) administration rent
for property management services in the amount of 3.0% of the Base Rent (but only if Operating Expenses does not include the costs
of a third-party property manager for the Building), and (iii) any and all other amounts Tenant assumes or agrees to pay under
the provisions of this Lease, including, without limitation, any and all other sums that may become due by reason of any default
of Tenant or failure to comply with the agreements, terms, covenants and conditions of this Lease to be performed by Tenant, after
any applicable notice and cure period.

 

4.          Base
Rent Adjustments. Base Rent shall be increased on each annual anniversary of the first day of the first full month during the
Term of this Lease (each an “Adjustment Date”) by multiplying the Base Rent payable immediately before such
Adjustment Date by the Rent Adjustment Percentage and adding the resulting amount to the Base Rent payable immediately before such
Adjustment Date. Base Rent, as so adjusted, shall thereafter be due as provided herein. Base Rent adjustments for any fractional
calendar month shall be prorated. 

 

5.          Operating
Expense Payments. Landlord shall deliver to Tenant a written estimate of Operating Expenses for each calendar year during the
Term (the “Annual Estimate”), which may be revised by Landlord from time to time during such calendar year.
During each month of the Term, on the same date that Base Rent is due, Tenant shall pay Landlord an amount equal to 1/12th
of Tenant’s Share of the Annual Estimate. Payments for any fractional calendar month shall be prorated.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 5

    

 

(a)         The
term “Operating Expenses” means all costs and expenses of any kind or description whatsoever incurred or accrued
each calendar year by Landlord with respect to the Building (including the Building’s Share of all costs and expenses of
any kind or description incurred or accrued by Landlord with respect to the Project which are not specific to the Building or any
other building located in the Project) (including, without duplication, Taxes (as defined in Section 10), project related
costs in connection with the shell and core of the Building, site improvements, transportation, maintenance, Common Area utilities,
PILOT payments, insurance, capital repairs and improvements amortized (with interest at the Default Rate) over the lesser of 7
years and the useful life of such capital items, the costs of any third-party property manager for the Building, and the costs
and expenses of maintaining, repairing, replacing and operating the Building and the Project, excluding only:

 

(i)          the
original construction costs of the Project and costs of correcting defects in such original construction; 

 

(ii)         capital
expenditures for expansion of the Project;

 

(iii)        interest,
principal payments of any Mortgage (as defined in Section 28) debts of Landlord, financing costs and amortization of funds
borrowed by Landlord, whether secured or unsecured and all payments of base rent (but not taxes or operating expenses) under any
ground lease or other underlying lease of all or any portion of the Project;

 

(iv)        depreciation
of the Project (provided that the exclusion of depreciation shall not preclude inclusion of amortization of capital improvements,
which is includable in Operating Expenses in accordance with the terms of this Lease);

 

(v)         advertising,
legal and space planning expenses and leasing commissions and other costs and expenses incurred in procuring and leasing space
to tenants for the Project, including any leasing office maintained in the Project, free rent and construction allowances for tenants;

 

(vi)        legal
and other expenses incurred in the negotiation or enforcement of leases;

 

(vii)       costs
of completing, fixturing, improving, renovating, painting, redecorating or other work, which Landlord pays for or performs for
other tenants within their premises, and costs of correcting defects in such work; in each instance other than those ordinary building
repairs and maintenance to Building structures, windows and Building Systems;

 

(viii)      [intentionally
omitted];

 

(ix)         costs
to be reimbursed by other tenants of the Project or Taxes to be paid directly by Tenant or other tenants of the Project, whether
or not actually paid;

 

(x)          salaries,
wages, benefits and other compensation paid to officers and employees of Landlord who are not assigned in whole or in part to the
operation, management, maintenance or repair of the Project;

 

(xi)         general
organizational, administrative and overhead costs relating to maintaining Landlord’s existence, either as a corporation,
partnership, or other entity, including general corporate, legal and accounting expenses;

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 6

    

 

(xii)        costs
(including attorneys’ fees and costs of settlement, judgments and payments in lieu thereof) incurred in connection with disputes
with tenants, other occupants, or prospective tenants, and costs and expenses, including legal fees, incurred in connection with
negotiations or disputes with employees, consultants, management agents, leasing agents, purchasers or mortgagees of the Building;

 

(xiii)       costs
incurred by Landlord due to the violation by Landlord, its employees, agents or contractors or any tenant of the terms and conditions
of any lease of space in the Project or any Legal Requirement (as defined in Section 8);

 

(xiv)      penalties,
fines or interest incurred as a result of Landlord’s inability or failure to make payment of Taxes and/or to file any tax
or informational returns when due, or from Landlord‘s failure to make any payment of Taxes required to be made by Landlord
hereunder before delinquency;

 

(xv)       overhead
and profit increment paid to Landlord or to subsidiaries or affiliates of Landlord for goods and/or services in or to the Project
to the extent the same materially exceeds the costs of such goods and/or services rendered by unaffiliated third parties on a competitive
basis;

 

(xvi)      costs
of Landlord's charitable or political contributions, or of fine art maintained at the Project;

 

(xvii)     costs
in connection with services (including electricity), items or other benefits of a type which are not standard for the Project and
which are not available to Tenant without specific charges therefor, but which are provided to another tenant or occupant of the
Project, whether or not such other tenant or occupant is specifically charged therefor by Landlord;

 

(xviii)    costs
incurred in the sale or refinancing of the Project;

 

(xix)       subject
to Section 10(a), net income taxes of Landlord or the owner of any interest in the Project, franchise, capital stock, gift,
estate or inheritance taxes or any federal, state or local documentary taxes imposed against the Project or any portion thereof
or interest therein; and

 

(xx)        any
expenses otherwise includable within Operating Expenses to the extent actually reimbursed by persons other than tenants of the
Project under leases for space in the Project.

 

(b)         Within
120 days after the end of each calendar year (or such longer period as may be reasonably required), Landlord shall furnish to Tenant
a statement (an “Annual Statement”) showing in reasonable detail: (a) the total and Tenant’s Share of
actual Operating Expenses for the previous calendar year, and (b) the total of Tenant’s payments in respect of Tenant's Share
of Operating Expenses for such year. If Tenant’s Share of actual Operating Expenses for such year exceeds Tenant’s
payments of Tenant's Share of Operating Expenses for such year, then the excess shall be due and payable by Tenant as Rent within
30 days after delivery of such Annual Statement to Tenant. If Tenant's payments of Operating Expenses for such year exceed Tenant's
Share of actual Operating Expenses for such year, then Landlord shall pay the excess to Tenant within 30 days after delivery of
such Annual Statement, except that after the expiration, or earlier termination of the Term or if Tenant is delinquent in its obligation
to pay Rent, Landlord shall pay the excess to Tenant after deducting all other amounts due Landlord.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 7

    

 

(c)         Each
Annual Statement shall be final and binding upon Tenant unless Tenant, within 30 days after Tenant’s receipt thereof, shall
contest any item therein by giving written notice to Landlord, specifying each item contested and the reason therefor. Operating
Expenses for the calendar years in which Tenant’s obligation to share therein begins and ends shall be prorated. Notwithstanding
anything set forth herein to the contrary, if the Building is not at least 95% occupied on average during any year of the Term,
Tenant’s Share of Operating Expenses for such year shall be computed as though the Building had been 95% occupied on average
during such year. “Tenant’s Share” shall be the percentage set forth in the Basic Lease Provisions as
Tenant’s Share as reasonably adjusted by Landlord for changes in the physical size of the Premises or the Project occurring
thereafter. Landlord may equitably increase Tenant’s Share (or Tenant's Share of Operating Expenses, as the case may be)
for any item of expense or cost reimbursable by Tenant that relates to a repair, replacement, or service that benefits only the
Premises or only a portion of the Project that includes the Premises or that varies with occupancy or use. Base Rent, Tenant’s
Share of Operating Expenses and all Additional Rent and other amounts payable by Tenant to Landlord hereunder are collectively
referred to herein as “Rent.” 

 

6.          Rent
Abatement. Notwithstanding anything to the contrary herein, provided that there is not a Default by Tenant hereunder, Base
Rent and Operating Expenses shall be abated during the period from the Commencement Date until (but not including) the Rent Commencement
Date.

 

7.          Security
Deposit. Tenant shall deposit with Landlord, upon delivery of an executed copy of this Lease to Landlord, a security
deposit (the “Security Deposit”) for the performance of all of Tenant’s obligations hereunder in the amount
set forth in the Basic Lease Provisions, which Security Deposit shall be in the form of an unconditional and irrevocable letter
of credit (the “Letter of Credit”): (i) in form and substance satisfactory to Landlord, (ii) naming Landlord
as beneficiary, (iii) expressly allowing Landlord to draw upon it at any time from time to time by delivering to the issuer notice
that Landlord is entitled to draw thereunder, (iv) issued by an FDIC-insured financial institution satisfactory to Landlord, and
(v) redeemable by presentation of a sight draft in the state of Landlord's choice. If Tenant does not provide Landlord with a substitute
Letter of Credit complying with all of the requirements hereof at least 30 days before the stated expiration date of any then current
Letter of Credit, Landlord shall have the right to draw the full amount of the current Letter of Credit and hold the funds drawn
in cash without obligation for interest thereon as the Security Deposit. The Security Deposit shall be held by Landlord as security
for the performance of Tenant’s obligations under this Lease. The Security Deposit is not an advance rental deposit or a
measure of Landlord’s damages in case of Tenant’s default. Upon each occurrence of a Default (as defined in Section
21), Landlord may use all or any part of the Security Deposit to pay delinquent payments due under this Lease, and the cost
of any damage, injury, expense or liability caused by such Default, without prejudice to any other remedy provided herein or provided
by law. Upon any such use of all or any portion of the Security Deposit, Tenant shall pay Landlord on demand the amount that will
restore the Security Deposit to the amount set forth in the Basic Lease Provisions or Tenant shall promptly provide Landlord with
an amendment to the Letter of Credit reflecting and ratifying Landlord’s draw thereunder and Tenant’s subsequent restoration
of the Letter of Credit to the original amount. Tenant hereby waives the provisions of any law, now or hereafter in force, which
provide that Landlord may claim from a security deposit only those sums reasonably necessary to remedy defaults in the payment
of Rent, to repair damage caused by Tenant or to clean the Premises, it being agreed that Landlord may, in addition, claim those
sums reasonably necessary to compensate Landlord for any other loss or damage, foreseeable or unforeseeable, caused by the act
or omission of Tenant or any officer, employee, agent or invitee of Tenant. Upon bankruptcy or other debtor-creditor proceedings
against Tenant, the Security Deposit shall be deemed to be applied first to the payment of Rent and other charges due Landlord
for periods prior to the filing of such proceedings. Upon any such use of all or any portion of the Security Deposit, Tenant shall,
within 5 days after demand from Landlord, restore the Security Deposit to its original amount. If Tenant shall fully perform every
provision of this Lease to be performed by Tenant, the Security Deposit, or any balance thereof (i.e., after deducting therefrom
all amounts to which Landlord is entitled under the provisions of this Lease), shall be returned to Tenant (or, at Landlord’s
option, to the last assignee of Tenant’s interest hereunder) within 90 days after the expiration or earlier termination of
this Lease. In the event the issuer of the Letter of Credit experiences a downgrade of its debt rating below “A-” by
Standard & Poors Rating Services, a division of The McGraw-Hill Companies, Inc. (“S&P”) or the equivalent
rating by Moody’s Investor Services, Inc. (“Moody’s”) at any time during which Tenant is obligated
to provide the Letter of Credit, Landlord shall be entitled, in Landlord’s sole discretion, to receive a replacement Letter
of Credit from an issuing bank with a debt rating of “AA” by S&P or the equivalent rating by Moody’s or better).

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 8

    

 

If Landlord transfers
its interest in the Project or this Lease, Landlord shall either (a) transfer any Security Deposit then held by Landlord to a person
or entity assuming Landlord's obligations under this Section 7, or (b) return to Tenant any Security Deposit then held by
Landlord and remaining after the deductions permitted herein. Upon such transfer to such transferee or the return of the Security
Deposit to Tenant, Landlord shall have no further obligation with respect to the Security Deposit, and Tenant's right to the return
of the Security Deposit shall apply solely against Landlord's transferee. The Security Deposit is not an advance rental deposit
or a measure of Landlord's damages in case of Tenant's default. Landlord's obligation respecting the Security Deposit is that of
a debtor, not a trustee, and no interest shall accrue thereon.

 

Tenant covenants that
it will not assign or encumber, or attempt to assign or encumber, the Security Deposit. Neither Landlord, nor its successors or
assigns, shall be bound by any such assignment, encumbrance, attempted assignment or attempted encumbrance. It is agreed that the
provisions of this Section 7 shall apply to every sale, transfer or assignment made of the security to a new Landlord. Tenant
shall pay and be liable for any and all fees arising from any transfer of the Letter of Credit upon transfers of ownership of the
Project, Building or Premises.

 

8.          Use.

 

(a)              Tenant
shall have 24 hours per day, 7 days per week access to its Premises, the Building, and the parking area, subject to restricted
access necessary for repairs or emergency conditions. Tenant shall use the Premises solely for the Permitted Use set forth in the
Basic Lease Provisions, and in compliance with all present and future laws, orders, judgments, ordinances, regulations, codes,
directives, permits, licenses, covenants and restrictions of all state, federal, municipal and local governments, departments,
commissions and boards and any direction of any public officer pursuant to law, and all orders, rules and regulations of the New
York Board of Fire Underwriters, Insurance Services Office, or any similar body, in each case, applicable to the Premises and the
use and occupancy thereof, including, without limitation, the Americans With Disabilities Act, 42 U.S.C. § 12101, et seq.
(together with the regulations promulgated pursuant thereto, “ADA”) (collectively, “Legal Requirements”
and each, a “Legal Requirement”). Tenant shall not occupy, use or operate the Premises, or allow the Premises
or any part thereof to be occupied, used or operated for any unlawful purpose or in violation of any certificate of occupancy affecting
the Building and/or the Project or for any use that may constitute a nuisance, public or private. Tenant shall not permit any part
of the Premises to be used as a “place of public accommodation”, as defined in the ADA or any similar legal requirement.
Tenant will use the Premises in a careful, safe and proper manner and will not commit or permit waste, overload the floor or structure
of the Premises, subject the Premises to any use that would damage the Premises or obstruct or interfere with the rights of Landlord
or other tenants or occupants of the Project, including, without limitation, conducting or giving notice of any auction, liquidation,
or going out of business sale on the Premises.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 9

    

 

(b)              Immediately
upon its discovery of any violation or breach of any Legal Requirement, this Lease or any Superior Instrument, Tenant shall take
all necessary steps, legal and equitable, to compel the cure of such violation or breach, including, if necessary, the removal
from the Premises of any subtenants or licensees using a portion of the Premises.

 

(c)              Tenant
will not use or permit the Premises to be used for any purpose or in any manner that is prohibited under the Ground Lease (as defined
in Section 28) or that would void Tenant’s or Landlord’s insurance, increase the insurance risk, or cause the
disallowance of any sprinkler or other credits.

 

(d)              Tenant
shall reimburse Landlord promptly upon demand for any additional premium charged for any such insurance policy by reason of Tenant’s
failure to comply with the provisions of this Section 7 or otherwise caused by Tenant’s use and/or occupancy of the
Premises.

 

(e)              Tenant
shall cause any equipment or machinery to be installed in the Premises so as to reasonably prevent odors, sounds or vibrations
from the Premises from extending into Common Areas, or other space in the Project. Tenant shall not place any machinery or equipment
weighing 500 pounds or more in or upon the Premises or transport or move such items through the Common Areas of the Project or
in the Project elevators without the prior written consent of Landlord. Landlord reserves the right to prescribe the weight and
position of all safes, files, paper and book storage facilities, business machines and other heavy equipment and installations.

 

(f)               Tenant
shall not, without the prior written consent of Landlord, use the Premises in any manner which will require ventilation, air exchange,
heating, gas, steam, electricity or water beyond the existing capacity of the Project as proportionately allocated to the Premises
based upon Tenant’s Share as usually furnished for the Permitted Use, nor shall Tenant use the Premises in a manner that
results in transmissions from the Premises at a frequency which interferes with any other tenant’s use of any portion of
the Building or the Project other than the Premises.

 

(g)              Tenant
shall not use the Premises or any part thereof, or permit the Premises or any part thereof to be used for the preparation, dispensing,
consumption or sale of food or beverages in any manner whatsoever, whether for “on” or “off” premises consumption
(other than the consumption of food by employees and invitees of Tenant).

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 10

    

 

9.          Holding
Over. If, with Landlord’s express written consent, Tenant retains possession of the Premises after the expiration or
earlier termination of the Term, (i) unless otherwise agreed in such written consent, such possession shall be subject to immediate
termination by Landlord at any time, or shall become a tenant at sufferance upon the terms described hereinbelow, (ii) all of the
other terms and provisions of this Lease (including, without limitation, the adjustment of Base Rent pursuant to Section 4
hereof) shall remain in full force and effect (excluding any expansion or renewal option or other similar right or option) during
such holdover period, (iii) Tenant shall continue to pay Base Rent in the amount payable upon the date of the expiration or earlier
termination of this Lease or such other amount as Landlord may indicate, in Landlord’s sole and absolute discretion, in such
written consent, and (iv) all other payments shall continue under the terms of this Lease. The parties recognize and agree that
the damage to Landlord resulting from any failure by Tenant to timely surrender possession of the Premises as aforesaid will be
extremely substantial, will exceed the amount of the monthly installments of the Base Rent and Rental theretofore payable hereunder,
and will be impossible to accurately measure. Tenant therefore agrees that if Tenant remains in possession of the Premises after
the expiration or earlier termination of the Term without the express written consent of Landlord, then, in addition to any other
rights or remedies Landlord may have hereunder or at law, and without in any manner limiting Landlord's right to demonstrate and
collect any damages suffered by Landlord and arising from Tenant's failure to surrender the Premises as provided herein, (A) Tenant
shall become a tenant at sufferance upon the terms of this Lease except that the monthly rental shall be equal to 200% of the greater
of the Rent in effect during the last 30 days of the Term and the then fair market rental value for the Premises, and (B) Tenant
shall be responsible for all damages suffered by Landlord resulting from or occasioned by Tenant’s holding over, including
consequential damages. No holding over by Tenant, whether with or without consent of Landlord, shall operate to extend this Lease
except as otherwise expressly provided, and this Section 9 shall not be construed as consent for Tenant to retain possession
of the Premises. Acceptance by Landlord of Rent after the expiration of the Term or earlier termination of this Lease shall not
result in a renewal or reinstatement of this Lease. The acceptance by Landlord of any such use and occupancy payment by Tenant
pursuant to this Section 9 shall in no event preclude Landlord from commencing and prosecuting a holdover or summary eviction
proceeding, and the provisions of this Section 9 shall be deemed to be an “agreement expressly providing otherwise”
within the meaning of Section 232-c of the Real Property Law of the State of New York and any successor or similar law of like
import. Nothing contained in this Section 9 shall (i) imply any right of Tenant to remain in the Premises after the expiration
of the Term without the execution of a new lease, (ii) imply any obligation of Landlord to grant a new lease or (iii) be construed
to limit any right or remedy that Landlord has against Tenant as a holdover tenant or trespasser and no acceptance by Landlord
of payments from Tenant after the Expiration Date shall be deemed to be other than on account of the amount to be paid by Tenant
in accordance with the provisions of this Section 9. The provisions of this Section 9 shall survive the expiration
or earlier termination of this Lease.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 11

    

 

10.         Taxes.

 

(a)         Landlord
shall pay, as part of Operating Expenses, all taxes, levies, fees, assessments and governmental charges of any kind, existing as
of the Commencement Date or thereafter enacted (collectively referred to as “Taxes”), imposed by any federal,
state, regional, municipal, local or other governmental authority or agency, including, without limitation, quasi-public agencies
(collectively, “Governmental Authority”) during the Term, including, without limitation, all Taxes: (i) imposed
on or measured by or based, in whole or in part, on rent payable to (or gross receipts received by) Landlord under this Lease and/or
from the rental by Landlord of the Project or any portion thereof, or (ii) based on the square footage, assessed value or other
measure or evaluation of any kind of the Premises or the Project, or (iii) assessed or imposed by or on the operation or maintenance
of any portion of the Premises or the Project, including parking, or (iv) assessed or imposed by, or at the direction of, or resulting
from Legal Requirements, or interpretations thereof, promulgated by any Governmental Authority, or (v) imposed as a license or
other fee, charge, tax, or assessment on Landlord’s business or occupation of leasing space in the Project, or (vi) any taxes
or assessments levied after the date of this Lease in whole or in part for public benefits to the Project, including without limitation
any Business Improvement District (“BID”) tax increment financing (“TIF”) or Commercial Rent
Occupancy Tax (“CROT”) taxes and assessments payable by Landlord and any and all other governmental and quasi-governmental
assessments) without taking into account any discount that Landlord may receive by virtue of any early payment of Taxes. Landlord
may contest by appropriate legal proceedings the amount, validity, or application of any Taxes or liens securing Taxes. Taxes shall
include all PILOT and other impositions and costs for which Landlord is responsible under any Superior Lease (as defined in Section
28) including without limitation under Articles 3 and 4 of the Ground Lease or under the IDA Lease Documents
(as defined in Section 28). Taxes shall not take into account any exemption which Landlord is entitled to under any governmental
incentive program for investment and/or employment creation where Landlord is the induced party including without limitation the
Industrial and Commercial Incentive Program (“ICIP”) or under the IDA Lease Documents or Ground Lease or any
other governmental incentive program. Taxes shall not include any net income taxes, franchise, capital stock, gift, estate or inheritance
taxes imposed on Landlord or the owner of any interest in the Project or any federal, state or local documentary taxes imposed
against the Project or any portion thereof or interest therein, except to the extent the same, however denominated, are imposed
in substitution for any Taxes payable hereunder as a result of any change in the manner of taxation of the ownership or operation
of real estate in which case the same shall be deemed to be included within the definition of the term “Taxes.”
If any such Tax is levied or assessed directly against Tenant, then Tenant shall be responsible for and shall pay the same at such
times and in such manner as the taxing authority shall require. Tenant shall pay, prior to delinquency, any and all Taxes levied
or assessed against any personal property or trade fixtures placed by Tenant in the Premises, whether levied or assessed against
Landlord or Tenant. If any Taxes on Tenant’s personal property or trade fixtures are levied against Landlord or Landlord’s
property, or if the assessed valuation of the Project is increased by a value attributable to improvements in or alterations to
the Premises, whether owned by Landlord or Tenant and whether or not affixed to the real property so as to become a part thereof,
higher than the base valuation on which Landlord from time-to-time allocates Taxes to all tenants in the Project, Landlord shall
have the right, but not the obligation, to pay such Taxes. Landlord’s determination of any excess assessed valuation shall
be binding and conclusive, absent manifest error. The amount of any such payment by Landlord shall constitute Additional Rent due
from Tenant to Landlord immediately upon demand. With respect to any tax year, all reasonable and customary expenses, including
attorneys' fees and disbursements, experts' and other witnesses' fees, incurred in contesting the validity or amount of any Taxes
or in obtaining a refund of Taxes shall be considered as part of the Taxes for such tax year. Special assessments, if any, shall
be deemed paid in the maximum number of installments allowed by the Governmental Authority having jurisdiction thereover, notwithstanding
that Landlord may elect to pay the same on a different schedule. If at any time the methods of
taxation prevailing as of the date hereof shall be altered so that in lieu of or as an express substitute for the whole or any
part of the Taxes, assessments, rents, rates, charges, levies or impositions now assessed, levied or imposed upon all or any part
of the Project or any part thereof, there shall be assessed, levied or imposed (1) a tax, assessment, levy, imposition or charge
based on the income or rents received therefrom, whether or not wholly or partially as a capital levy or otherwise, or (2) a tax,
assessment, levy, imposition or charge measured by or based in whole or in part upon all or any part of the Project, or (3) a license
fee measured by the rents, or (4) any other tax, assessment, levy, imposition, charge or license fee with respect to the Project,
or any part thereof, however described or imposed, then all such taxes, assessments, levies, impositions, charges or license fees
or the part thereof so measured or based shall be deemed to be Taxes.

 

(b)         Tenant
hereby covenants and agrees to (i) pay any and all CROT taxes and assessments payable by Landlord with respect to any rent due
hereunder, (ii) pay any and all New York City and New York state transfer taxes, sales taxes and any and all other taxes payable
by or on behalf of Tenant, as the same shall become due or payable, and (iii) file all tax returns required to be filed in connection
with the foregoing.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 12

    

 

11.        Parking.
Subject to all matters of record, Force Majeure, a Taking (as defined in Section 20 below), the terms and conditions of
this Lease and the exercise by Landlord of its rights hereunder, Tenant shall have the right, in common with other tenants of the
Project pro rata in accordance with the rentable area of the Premises and the rentable areas of the Project occupied by such other
tenants, to park in those areas designated for non-reserved parking, subject in each case to Landlord’s rules and regulations
and subject to the rights of ingress and egress of other tenants and their employees, agents and invitees to other areas of the
Project, provided, however, that Landlord shall have the right, without notice, in an emergency and otherwise upon not less than
five (5) days’ written notice to relocate all or part of the non-reserved parking to other locations in the parking areas
of the Project, and/or to suspend or terminate the right to use any or all the parking spaces. Landlord may allocate parking spaces
among Tenant and other tenants in the Project pro rata as described above if Landlord determines that such parking facilities are
becoming crowded.

 

12.        Utilities;
Services; Refuse and Trash.

 

(a)         General.         Landlord
shall provide, subject to the terms of this Section 12, water, electricity, heat, steam, air conditioning, ventilating,
light, power, telephone, sewer, and fire sprinklers to the extent the Project is plumbed for such services (collectively, “Utilities”).
Landlord shall pay, as Operating Expenses or subject to Tenant’s obligation to reimburse the same (in which event the same
shall not be included in Operating Expenses), for all Utilities used by Tenant within Suite 940 and for all maintenance charges
for such Utilities, and any storm sewer charges or other similar charges for Utilities imposed by any Governmental Authority or
Utility provider, and any taxes, penalties, surcharges or similar charges thereon. Tenant acknowledges that Landlord is not the
generator of Utilities and that Landlord's obligation to deliver Utilities to the Premises pursuant to this Lease consequently
is subject to the provision of electrical energy and water service to the Project, as applicable, by the respective utility company
responsible for delivering same to the Project. Landlord shall have no liability for the availability, capacity, quality, continuity
or character of service of Utilities, and no eviction or constructive eviction of Tenant, termination of this Lease or abatement
of Rent shall arise due to, nor shall Landlord have any liability due to any loss, cost, claim, damage or expense arising from
the availability, capacity, quality, continuity or character of service of Utilities or any interruption, deterioration or removal
of any of the foregoing, except as caused by Landlord’s willful misconduct. Tenant acknowledges that the capacity of such
utilities available to the Premises is part of the overall capacity of such utilities available to the Project for its use on a
non-exclusive basis in common with all other tenants at the Project. Tenant agrees to limit use of water and sewer with respect
to Common Areas to normal restroom use. 

 

(b)        Special
Provisions Regarding Electricity. 

 

(i)          In
the event that any tax shall be imposed upon Landlord’s receipts from the sale, use or resale of electrical energy or any
other utility service to Tenant, the pro rata share allocable to such service received by Tenant shall be passed onto, included
in the bill of, and paid by Tenant if and to the extent not prohibited by applicable Legal Requirements.

 

(ii)         Tenant
shall enter into such modifications of this Lease as Landlord may from time to time reasonably request in connection with any requirement
of the New York State Public Service Commission, or any successor thereto, or any requirement of law pertaining to the supplying
of electrical service or the charges therefor under any provision of the Lease. If because of any such requirement, any provision
of this Section cannot be given full effect, whether with respect to any past period or any future period, the parties shall enter
into such modifications of the Lease setting forth substitute provisions, consistent with such requirements, which, to the maximum
extent possible, achieve the intended purposes of the provisions of this Section which cannot be given full effect.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 13

    

 

(c)          Refuse
and Trash. Landlord shall provide refuse and trash collection and janitorial services at
the Building for ordinary office refuse and rubbish and cleaning, and the cost of such services shall be included in Operating
Expenses. To the extent that the refuse and trash and/or cleaning needs generated by Tenant exceeds the refuse and trash and/or
cleaning needs customarily generated by other tenants of the Building, Tenant shall pay to Landlord the costs that Landlord reasonably
incurs for such removal and/or cleaning, within 10 days after rendition of bills therefor, as Additional Rent. In respect of refuse
and trash other than ordinary office refuse and rubbish (such as bio/medical waste, “wet trash” and construction debris,
and cleaning with respect thereto), at Landlord's option (i) Landlord shall provide collection and janitorial services for such
refuse and trash, and Tenant shall pay to Landlord an amount equal to 105% of the Landlord’s cost therefor, within 10 days
after rendition of bills therefor, as Additional Rent, or (ii) Tenant shall contract directly with the third-party service provider
(acceptable to Landlord in its sole discretion) for the provision of such services and, in such case, Tenant shall pay
such service provider directly, prior to delinquency. In all cases, Tenant shall store and stage
all its waste, refuse, trash and recyclables within its Premises or in such enclosure areas as may be designated by Landlord and
shall keep the Premises in a neat and clean condition. Tenant shall not dispose of any refuse in the Common Areas, and if Tenant
does so, Tenant shall be liable for Landlord's reasonable charge for such removal. Tenant shall comply with all Legal Requirements,
whether imposed on Landlord or Tenant, regarding the collection, sorting, separation and recycling of waste products, garbage,
refuse and trash in the Premises and cleaning the Premises. Upon request by Landlord, Tenant shall sort and separate into categories
designated by Landlord and shall place in separate receptacles (as may be designated by Landlord) all waste products, garbage,
refuse and trash in the Premises.

 

(d)          Loading
Dock and Freight Elevator. Landlord shall provide, on a non-exclusive, first-come, first-served
basis, freight elevator service to the floor on which the Premises are located and access to a loading dock adjacent to such freight
elevator for Tenant's deliveries in and out of the Premises in connection with the Permitted Use. Tenant's use of the freight
elevator and the loading dock shall be subject to the Superior Instruments, the Rules and Regulations, Landlord's security requirements
for the Building and/or the Project, and the terms of this Lease. Landlord shall have the right to change the operation
or manner of operation of any of the elevators in the Building and/or to discontinue temporarily the use of any one or more cars
in any of the elevator banks provided that at all times there will be at least one passenger elevator serving the Premises at
all times (subject to such passenger elevator not being in service due to repairs or alterations being made thereto).

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 14

    

 

13.         Alterations
and Tenant’s Property.

 

(a)          Any
alterations, additions, or improvements made to the Premises by or on behalf of Tenant, if any, including additional locks or bolts
of any kind or nature upon any doors or windows in the Premises, but excluding installation, removal or realignment of furniture
systems (other than removal of furniture systems owned or paid for by Landlord) not involving any modifications to the structure
of the Building or connections (other than by ordinary plugs or jacks) to Building Systems (as defined in Section 13) (“Alterations”)
shall be subject to Landlord’s prior written consent, which may be given or withheld in Landlord’s sole discretion
if any such Alteration affects the structure of the Building or Building Systems, or if Landlord deems that such proposed Alteration
will adversely affect Landlord's ability to re-lease the Premises, but which shall otherwise not be unreasonably withheld or delayed.
If Landlord approves any Alterations, Landlord may impose such conditions on Tenant in connection with the commencement, performance
and completion of such Alterations as Landlord may deem appropriate in Landlord’s reasonable discretion. Any request for
approval shall be in writing, delivered not less than 15 business days in advance of any proposed construction, and accompanied
by plans, specifications, bid proposals, work contracts and such other information concerning the nature and cost of the Alterations
as may be reasonably requested by Landlord, including the identities and mailing addresses of all persons performing work or supplying
materials. Landlord’s right to review plans and specifications and to monitor construction shall be solely for its own benefit,
and Landlord shall have no duty to ensure that such plans and specifications or construction comply with applicable Legal Requirements.
Tenant shall cause, at its sole cost and expense, all Alterations to comply with any applicable insurance requirements and with
Legal Requirements and shall implement at its sole cost and expense any alteration or modification required by Legal Requirements
as a result of any Alterations. Tenant shall pay to Landlord, as Additional Rent, on demand an amount equal to 10% of all charges
incurred by Tenant or its contractors or agents in connection with any Alteration to cover Landlord’s overhead and expenses
for plan review, coordination, scheduling and supervision. Before Tenant begins any Alteration, Tenant shall post on and about
the Premises notices of non-responsibility pursuant to applicable law. Tenant shall reimburse Landlord for, and indemnify and hold
Landlord harmless from, any expense incurred by Landlord by reason of faulty work done by Tenant or its contractors, delays caused
by such work, or inadequate cleanup.

 

(b)          In
the event Tenant installs a security systems or additional locks, Tenant shall supply Landlord with the necessary card(s) or key(s)
and security codes to permit entry in the event of an emergency endangering life or property. 

 

(c)          Tenant
shall furnish security or make other arrangements satisfactory to Landlord to assure payment for the completion of all Alterations
work free and clear of liens, and shall provide (and cause each contractor or subcontractor to provide) certificates of insurance
for workers' compensation and other coverage in amounts and from an insurance company satisfactory to Landlord protecting Landlord
against liability for personal injury or property damage during construction. Upon completion of any Alterations, Tenant shall
deliver to Landlord: (i) sworn statements setting forth the names of all contractors and subcontractors who did the work and final
lien waivers from all such contractors and subcontractors; and (ii) “as built” plans for any such Alteration.

 

(d)          Other
than (i) the items, if any, listed on Exhibit F attached hereto, (ii) any items agreed by Landlord in writing to be included
on Exhibit F in the future, and (iii) any trade fixtures, machinery, equipment and other personal property not paid for
or installed by Landlord which may be removed without damage to the Premises, which damage shall be repaired (including capping
or terminating utility hook-ups behind walls) by Tenant prior to the expiration or earlier termination of the Term (collectively,
“Tenant’s Property”), all property of any kind paid for by Landlord, all Alterations, real property fixtures,
built-in machinery and equipment, built-in casework and cabinets and other similar additions and improvements built into the Premises
so as to become an integral part of the Premises such as fume hoods which penetrate the roof or plenum area, built-in cold rooms,
built-in warm rooms, walk-in cold rooms, walk-in warm rooms, deionized water systems, glass washing equipment, autoclaves, chillers,
built-in plumbing, electrical and mechanical equipment and systems, and any power generator and transfer switch (collectively,
“Installations”) shall be and shall remain the property of Landlord during the Term and following the expiration
or earlier termination of the Term, shall not be removed by Tenant at any time during the Term and shall remain upon and be surrendered
with the Premises as a part thereof in accordance with Section 29 following the expiration or earlier termination of this
Lease; provided, however, that Landlord shall, at the time its approval of such Installation is requested notify
Tenant if it has elected to cause Tenant to remove such Installation upon the expiration or earlier termination of this Lease.
If Landlord so elects, Tenant shall remove such Installation upon the expiration or earlier termination of this Lease and restore
any damage caused by or occasioned as a result of such removal, including, when removing any of Tenant’s Property which was
plumbed, wired or otherwise connected to any of the Building Systems, capping off all such connections behind the walls of the
Premises and repairing any holes. In the event Tenant fails to remove any such Installation in accordance with the foregoing sentence,
Landlord may do so at Tenant’s expense. During any such restoration period that extends beyond the expiration or earlier
termination of the Term, Tenant shall pay Rent to Landlord as provided herein as if said space were otherwise occupied by Tenant.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 15

    

 

(e)          No
Alteration shall (i) affect the exterior walls, fascia or fenestration of the Building or the demising walls of the Premises,
(ii) affect any part of the Project other than the Premises or require any alterations, installations, improvements, additions
or other physical changes to be performed in or made to any portion of the Project other than the Premises, (iii) adversely
affect any service required to be furnished by Landlord to Tenant or to any other tenant or occupant of the Project, (iv) adversely
affect the functioning of any Building System, and (v) affect or require an amendment to (other than to confirm completion
of the Alteration) the Certificate of Occupancy for the Premises or for any other part of the Project. 

 

(f)          Tenant
covenants and agrees that no security agreement, lien, lease, conditional sales agreement, chattel mortgage or other title retention
or instrument of similar import (a “Security Agreement”) shall be placed upon any improvement made by Tenant
which is affixed to the Premises. In the event that any of Tenant's Property are purchased or acquired by Tenant subject to a Security
Agreement, Tenant agrees that no Security Agreement or Uniform Commercial Code filing statement shall be permitted to be filed
against the Premises, the Building or any other part of the Project. If any such lien, based on a Security Agreement or Uniform
Commercial Code filing statement, is filed against the Premises or any other part of the Project, Tenant shall, within 20 business
days following notice thereof from Landlord, cause such lien or notice to be removed or discharged at Tenant's cost and expense.

 

(g)          Tenant
shall use its commercially reasonable and diligent efforts to perform such Alterations and other work at such times and in such
manner as shall minimize any interference, disruption or disturbance from such performance.

 

(h)          Tenant
shall not, at any time prior to or during the Term, directly or indirectly employ, or permit the employment of, any contractor,
mechanic or laborer in the Premises, in connection with any Alteration, if such employment would interfere or cause any conflict
with other contractors, mechanics or laborers engaged in the construction, maintenance or operation of the Project by Landlord,
Tenant or others. In the event of any such interference or conflict, Tenant, upon demand of Landlord, shall cause all contractors,
mechanics or laborers causing such interference or conflict to leave the Building immediately.

 

14.         Landlord’s
and Tenant’s Repairs. Landlord, as an Operating Expense, shall maintain all of the structural and Building Systems (as
defined below) in good repair, reasonable wear and tear and uninsured losses and damages caused by Tenant, or by any of Tenant’s
agents, servants, employees, invitees and contractors (collectively, “Tenant Parties”) excluded. Losses and
damages caused by Tenant or any Tenant Party shall be repaired by Landlord at Tenant’s sole cost and expense. Landlord reserves
the right to stop Building Systems services when necessary (i) by reason of accident or emergency, or (ii) for planned repairs,
alterations or improvements, which are, in the judgment of Landlord, desirable or necessary to be made, until said repairs, alterations
or improvements shall have been completed. Landlord shall have no responsibility or liability for failure to supply Building Systems
services during any such period of interruption; provided, however, that Landlord shall, except in case of emergency,
make a commercially reasonable effort to give Tenant 24 hours advance notice of any planned stoppage of Building Systems services
for routine maintenance, repairs, alterations or improvements. Tenant shall promptly give Landlord written notice of any repair
required to be effected by Landlord pursuant to this Section 14, after which Landlord shall have a reasonable opportunity
to effect such repair. Landlord shall not be liable for any failure to make any repairs or to perform any maintenance unless such
failure shall persist for an unreasonable time after Tenant’s written notice of the need for such repairs or maintenance.
Tenant waives its rights under any state or local law to terminate this Lease or to make such repairs at Landlord’s expense
and agrees that the parties’ respective rights with respect to such matters shall be solely as set forth herein. Repairs
required as the result of fire, earthquake, flood, vandalism, war, or similar cause of damage or destruction shall be controlled
by Section 19. As used herein, the term “Building Systems” shall mean, collectively, the HVAC, plumbing,
fire sprinkler, elevators and all other building systems located outside of the Premises and serving the Premises and other portions
of the Project, 

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 16

    

 

If at any time any
windows of the Premises are temporarily closed or darkened due to any Legal Requirement or by reason of repairs, maintenance, alterations,
or improvements to the Building, or any scaffolding or “sidewalk bridge” is erected in front of the Building due to
any Legal Requirement or by reason of any repairs, maintenance, alterations to the Building or any property adjacent to the Building,
Landlord shall not be liable for any damage Tenant may sustain thereby and Tenant shall not be entitled to any compensation therefor,
nor abatement or diminution of Base Rent or any other amount due under this Lease, nor shall the same release Tenant from its obligations
hereunder, in whole or in part, by reason of inconvenience or annoyance to Tenant, or injury to or interruption of Tenant's business,
or otherwise, nor impose any liability upon Landlord or its agents.

 

15.         Tenant’s
Repairs. Subject to Section 14 hereof, Tenant, at its expense, shall repair, replace and maintain in good condition
all portions of the Premises, including, without limitation, entries, doors, ceilings, interior windows, interior walls, and the
interior side of demising walls. Such repair and replacement may include capital expenditures and repairs whose benefit may extend
beyond the Term. Should Tenant fail to make any such repair or replacement or fail to maintain the Premises, Landlord shall give
Tenant notice of such failure. If Tenant fails to commence cure of such failure within 10 days of Landlord’s notice, and
thereafter diligently prosecute such cure to completion, Landlord may perform such work and shall be reimbursed by Tenant within
10 days after demand therefor; provided, however, that if such failure by Tenant creates or could create an emergency, Landlord
may immediately commence cure of such failure and shall thereafter be entitled to recover the costs of such cure from Tenant. Subject
to Sections 18 and 19, Tenant shall bear the full uninsured cost of any repair or replacement to any part of the
Project that result from damage caused by Tenant or any Tenant Party and any repair that benefits only the Premises. Tenant shall
not clean nor require, permit, suffer or allow any window in the Premises to be cleaned from the outside in violation of Section
202 of New York State Labor Law or any other applicable law, or of the Rules of the Board of Standards and Appeals, or of any other
Board or body having or asserting jurisdiction.

 

16.         Mechanic’s
Liens. Tenant shall discharge, by bond or otherwise, any mechanic’s lien filed against the Premises or against the Project
for work claimed to have been done for, or materials claimed to have been furnished to, Tenant within 10 days after the filing
thereof, at Tenant’s sole cost and shall otherwise keep the Premises and the Project free from any liens arising out of work
performed for, materials furnished to, or obligations incurred by Tenant. Should Tenant fail to discharge any lien described herein,
Landlord shall have the right, but not the obligation, to pay such claim or post a bond or otherwise provide security to eliminate
the lien as a claim against title to the Project and the cost thereof shall be immediately due from Tenant as Additional Rent.
If Tenant shall lease or finance the acquisition of office equipment, furnishings, or other personal property of a removable nature
utilized by Tenant in the operation of Tenant’s business, Tenant covenants that any Security Agreement, and any Uniform Commercial
Code Financing Statement filed as a matter of public record by any lessor or creditor of Tenant, shall upon its face or by exhibit
thereto indicate that such Security Agreement or Financing Statement is applicable only to removable personal property of Tenant
located within the Premises. Tenant shall cause to be inserted in any such Security Agreement the following provision: “Notwithstanding
anything to the contrary contained herein, this lease, chattel mortgage, conditional sales agreement, title retention agreement
or security agreement shall not create or be filed as a lien against the land, building and improvements comprising the real property
in which the goods, machinery, equipment, appliances or other personal property covered hereby are to be located or installed”;
and, in no event shall the address of the Project be furnished on any such Financing Statement without qualifying language as to
applicability of the lien only to removable personal property, located in an identified suite held by Tenant.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 17

    

 

17.         Indemnification.
Tenant shall indemnify, defend and hold harmless the Landlord, the entities (if any) comprising Landlord, each affiliate or subsidiary
of Landlord, and its and their partners, members, shareholders, officers, directors, employees and agents, Lessors (including,
without limitation, the City and any administrator of the Ground Lease) and Mortgagees (as defined in Section 28) (each
individually and collectively the “Landlord Indemnitees”) from and against any and all Claims against the Landlord
Indemnitees of whatever nature arising directly or indirectly from, or out of: (a) any negligence or willful misconduct by,
Tenant, its officers, members, managers, directors, partners, contractors, licensees, agents, servants, employees, invitees or
visitors, sublessees and assigns (b) any accident, injury, death or damage whatsoever caused to any Person or to the property
of any Person occurring within or about the Premises, (c) any accident, injury, death or damage whatsoever caused to any Person
or to the property of any Person occurring outside of the Premises but anywhere within or about the Land, where such accident,
injury, death or damage is caused (or is claimed to have been caused) by or otherwise involves an act or omission, or the negligence
or willful misconduct, of Tenant or Tenant's contractors, licensees, agents, servants, employees, invitees or visitors and (d)
any accident, injury, death or damage whatsoever caused to any Person or to the property of any Person occurring within or about
the Premises, where such accident, injury, death or damage is caused (or is claimed to have been caused) by or otherwise relates
to the use or occupancy of the Premises or a breach or default by Tenant in the performance of any of its obligations hereunder,
unless, in each case set forth in clauses (a) through (d), caused solely by the willful misconduct or negligence of Landlord. This
indemnity, defense and hold harmless agreement shall include indemnification from and against any and all liability, fines, suits,
demands, costs and expenses of any kind or nature (including reasonable attorneys' fees and disbursements) incurred in or in connection
with any such claim or proceeding brought thereon, and the defense thereof.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 18

    

 

18.         Insurance.

 

(a)         Landlord
shall maintain all risk property and, if applicable, sprinkler damage insurance covering the full replacement cost of the Project.
Landlord shall further procure and maintain commercial general liability insurance with a single loss limit of not less than $2,000,000
for bodily injury and property damage with respect to the Project. Landlord may, but is not obligated to, maintain such other insurance
and additional coverages as it may deem necessary, including, but not limited to, flood, environmental hazard and earthquake, loss
or failure of building equipment, errors and omissions, rental loss during the period of repair or rebuilding, workers’ compensation
insurance and fidelity bonds for employees employed to perform services and insurance for any improvements installed by Tenant
or which are in addition to the standard improvements customarily furnished by Landlord without regard to whether or not the same
are made a part of the Project. All such insurance shall be included as part of the Operating Expenses. The Project may be included
in a blanket policy (in which case the cost of such insurance allocable to the Project will be determined by Landlord based upon
the insurer’s cost calculations). Tenant shall also reimburse Landlord for any increased premiums or additional insurance
which Landlord reasonably deems necessary as a result of Tenant’s use of the Premises. Tenant (and, during the prosecution
of any I electrical current), water and sprinkler damage, and off-premises failure of power or other utility services) with 18
months of business interruption and extra expense coverage, covering the full replacement cost of all property and improvements
installed or placed in the Premises by Tenant at Tenant’s expense (including, without limitation, builder’s risk coverage
for all Alterations); workers’ compensation insurance with no less than the minimum limits required by law; employer’s
liability insurance with such limits as required by law; comprehensive automobile liability insurance (including automotive liability,
including pollution coverage, from loading and unloading) with combined bodily injury and property damage coverage limits, per
occurrence, of at least $1,000,000; and commercial general liability insurance and umbrella liability, in each case, for
minimum combined bodily injury and property damage coverage limits totaling $2,000,000 per occurrence and $5,000,000 in the aggregate.
The commercial general liability insurance policy shall name (i) Landlord, (ii) its officers, directors, employees, managers, agents,
invitees, contractors, subcontractors, general contractor (or construction manager, as applicable), (iii) Alexandria Real Estate
Equities, Inc., (iv) New York City Health and Hospitals Corporation (and any other Ground Landlord (as defined in Section 28)
from time to time), (v) the City, (vi) the IDA (as defined in Section 28), and (vii) the New York City Economic Development
Corporation (and any other Ground Lease (as defined in Section 28) administrator/agent from time to time) (collectively,
“Landlord Parties”), as additional insureds; insure on an occurrence and not a claims-made basis; be issued
by insurance companies which have a rating of not less than policyholder rating of A and financial category rating of at least
Class X in “Best’s Insurance Guide”; shall not be cancelable for nonpayment of premium unless 30 days prior written
notice shall have been given to Landlord from the insurer; contain a hostile fire endorsement and a contractual liability endorsement;
and provide primary coverage to Landlord (any policy issued to Landlord providing duplicate or similar coverage shall be deemed
excess over Tenant’s policies). Copies of such policies (if requested by Landlord), or certificates of insurance showing
the limits of coverage required hereunder and showing Landlord as an additional insured, along with reasonable evidence of the
payment of premiums for the applicable period, shall be delivered to Landlord by Tenant upon commencement of the Term and upon
each renewal of said insurance. Tenant’s policy may be a “blanket policy” with an aggregate per location endorsement
which specifically provides that the amount of insurance shall not be prejudiced by other losses covered by the policy. Tenant
shall, at least 5 days prior to the expiration of such policies, furnish Landlord with renewal certificates. In addition, upon
receipt by Tenant of any notice of cancellation or any other notice from the insurance carrier which may adversely affect the coverage
of the insureds under such policy of insurance, Tenant shall promptly deliver to Landlord and any other additional insured hereunder
a copy of such notice. If at any time Tenant (or its general contractor, contractors and/or subcontractors) shall fail to procure
or maintain all insurance required to be carried by Tenant pursuant to this Lease, Landlord may procure (but shall have no obligation
to procure) such insurance on behalf of Tenant (and its general contractor, contractors and/or subcontractors) and the cost thereof
shall be payable by Tenant upon demand. Such insurer(s) shall be selected by Tenant, subject to Landlord's approval, not to be
unreasonably withheld, conditioned or delayed. 

 

(b)         In
each instance where insurance is to name Landlord as an additional insured, Tenant shall upon written request of Landlord also
designate and furnish certificates so evidencing Landlord as additional insured to: (i) any lender of Landlord holding a security
interest in the Project or any portion thereof, (ii) the landlord under any lease wherein Landlord is tenant of the real property
on which the Project is located, if the interest of Landlord is or shall become that of a tenant under a ground or other underlying
lease rather than that of a fee owner, and/or (iii) any management company retained by Landlord to manage the Project.

 

(c)         The
property insurance obtained by Landlord and Tenant shall include a waiver of subrogation by the insurers and all rights based upon
an assignment from its insured, against Landlord or Tenant, and their respective officers, directors, employees, managers, agents,
invitees and contractors (“Related Parties”), in connection with any loss or damage thereby insured against.
Neither party nor its respective Related Parties shall be liable to the other for loss or damage caused by any risk insured against
under property insurance required to be maintained hereunder, and each party waives any claims against the other party, and its
respective Related Parties, for such loss or damage. The failure of a party to insure its property shall not void this waiver.
Landlord and its respective Related Parties shall not be liable for, and Tenant hereby waives all claims against such parties for,
business interruption and losses occasioned thereby sustained by Tenant or any person claiming through Tenant resulting from any
accident or occurrence in or upon the Premises or the Project from any cause whatsoever. If the foregoing waivers shall contravene
any law with respect to exculpatory agreements, the liability of Landlord or Tenant shall be deemed not released but shall be secondary
to the other’s insurer.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 19

    

 

(d)         Landlord
may require insurance policy limits to be raised to conform to requirements of Landlord’s lender and/or to bring coverage
limits to levels then being generally required of new tenants within the Project.

 

(e)         Tenant
acknowledges that Landlord shall not carry insurance on, and shall not be responsible for damage to, Tenant's Property or any Alterations,
betterments or improvements made by Tenant to the Premises. Tenant agrees that Landlord shall not be required to maintain insurance
coverage with respect to the portions of the Premises for which Tenant is required to maintain insurance in accordance with the
terms of this Lease.

 

19.         Restoration.

 

(a)         If,
at any time during the Term, the Project or the Premises are damaged or destroyed by a fire or other insured casualty, Landlord
shall notify Tenant within 60 days after discovery of such damage or destruction as to the amount of time Landlord reasonably estimates
it will take to restore the Project or the Premises, as applicable (the “Restoration Period”). If the Restoration
Period is estimated to exceed 12 months from the date that Landlord obtains all required permits to perform the restoration (the
“Maximum Restoration Period”), Landlord may, in such notice, elect to terminate this Lease as of the date that
is 75 days after the date of discovery of such damage or destruction. Unless Landlord so elects to terminate this Lease, Landlord
shall, subject to receipt of sufficient insurance proceeds (with any deductible to be treated as a current Operating Expense),
promptly restore the Premises (excluding any improvements installed by Tenant or by Landlord and paid for by Tenant unless
covered by the insurance Landlord maintains as Operating Expenses hereunder, in which case such improvements shall be included,
to the extent of such insurance proceeds, in Landlord’s restoration), subject to delays arising from the collection of insurance
proceeds, from Force Majeure events or as needed to obtain any license, clearance or other authorization of any kind required to
enter into and restore the Premises issued by any Governmental Authority having jurisdiction over the use, storage, handling, treatment,
generation, release, disposal, removal or remediation of Hazardous Materials (as defined in Section 31) in, on or about
the Premises (collectively referred to herein as “Hazardous Materials Clearances”); provided, however,
that if repair or restoration of the Premises is not substantially complete as of the end of the Maximum Restoration Period or,
if longer, the Restoration Period, Landlord may, in its sole and absolute discretion, elect not to proceed with such repair and
restoration, in which event Landlord shall be relieved of its obligation to make such repairs or restoration and this Lease shall
terminate as of the date that is 75 days after the later of: (i) discovery of such damage or destruction, or (ii) the date all
required Hazardous Materials Clearances are obtained, but Landlord shall retain any Rent paid and the right to any Rent payable
by Tenant prior to such election by Landlord or Tenant.

 

(b)         Tenant,
at its expense, shall promptly perform, subject to delays arising from the collection of insurance proceeds, from Force Majeure
(as defined in Section 35) events or from obtaining Hazardous Materials Clearances, all repairs or restoration not required
to be done by Landlord and shall promptly re-enter the Premises and commence doing business in accordance with this Lease. Notwithstanding
the foregoing, Landlord may terminate this Lease if the Premises are damaged during the last 1 year of the Term and Landlord reasonably
estimates that it will take more than 2 months to repair such damage, or if insurance proceeds are not available for such restoration.
Rent shall be abated from the date all required Hazardous Material Clearances are obtained until the repair and restoration of
the Premises is substantially completed, in the proportion which the area of the Premises, if any, which is not usable by Tenant
bears to the total area of the Premises, unless Landlord provides Tenant with other space during the period of repair that is suitable
for the temporary conduct of Tenant’s business. Such abatement shall be the sole remedy of Tenant, and except as provided
in this Section 19, Tenant waives any right to terminate this Lease by reason of damage or casualty loss.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 20

    

 

 

(c)         The
provisions of this Lease, including this Section 19, constitute an express agreement between Landlord and Tenant with respect
to any and all damage to, or destruction of, all or any part of the Premises, or any other portion of the Project, and any statute
or regulation which is now or may hereafter be in effect shall have no application to this Lease or any damage or destruction to
all or any part of the Premises or any other portion of the Project, the parties hereto expressly agreeing that this Section
19 sets forth their entire understanding and agreement with respect to such matters.

 

(d)         Tenant
hereby expressly waives the provision of Section 227 of the Real Property Law and agrees that the foregoing provisions of this
Section 19 shall govern and control in lieu thereof, this Section 19 being an express agreement.

 

20.         Condemnation.
If the whole or any material part of the Premises, the Building or the Project is taken for any public or quasi-public use under
governmental law, ordinance, or regulation, or by right of eminent domain, or by private purchase in lieu thereof (a “Taking”
or “Taken”), and the Taking would in Landlord’s reasonable judgment, either prevent or materially interfere
with Tenant’s use of the Premises or materially interfere with or impair Landlord’s ownership or operation of the Building
or Project, then upon written notice by Landlord this Lease shall terminate and Rent shall be apportioned as of said date. If part
of the Premises shall be Taken, and this Lease is not terminated as provided above, Landlord shall promptly restore the Premises
and the Project as nearly as is commercially reasonable under the circumstances to their condition prior to such partial Taking
and the rentable square footage of the Building, the rentable square footage of the Premises, Tenant’s Share of Operating
Expenses and the Rent payable hereunder during the unexpired Term shall be reduced to such extent as may be fair and reasonable
under the circumstances. Upon any such Taking, Landlord shall be entitled to receive the entire price or award from any such Taking
without any payment to Tenant, and Tenant hereby assigns to Landlord Tenant’s interest, if any, in such award. Tenant shall
have the right, to the extent that same shall not diminish Landlord’s award, to make a separate claim against the condemning
authority (but not Landlord) for such compensation as may be separately awarded or recoverable by Tenant for moving expenses and
damage to Tenant’s trade fixtures, if a separate award for such items is made to Tenant. Tenant hereby waives any and all
rights it might otherwise have pursuant to any provision of state law to terminate this Lease upon a partial Taking of the Premises
or the Project.

 

21.         Events
of Default. Each of the following events shall be a default (“Default”) by Tenant under this Lease:

 

(a)         Payment
Defaults. Tenant shall fail to pay any installment of Rent or any other payment hereunder when due, including, without limitation,
any penalties or interest accrued thereon.

 

(b)         Insurance.
Any insurance required to be maintained by Tenant pursuant to this Lease shall be canceled or terminated or shall expire or shall
be reduced or materially changed, or Landlord shall receive a notice of nonrenewal of any such insurance and Tenant shall fail
to obtain replacement insurance at least 20 days before the expiration, cancellation, termination, or reduction of, or material
change in, the current coverage.

 

(c)         Abandonment.
Tenant shall abandon the Premises.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 21

    

 

(d)         Improper
Transfer. Tenant shall assign, sublease or otherwise transfer (including, without limitation, by operation of law) or attempt
to transfer all or any portion of Tenant’s interest in this Lease or the Premises except as expressly permitted herein, or
Tenant’s interest in this Lease shall be attached, executed upon, or otherwise judicially seized and such action is not released
or dismissed within 90 days of the action.

 

(e)         Liens.
Tenant shall fail to discharge or otherwise obtain the release of any lien placed upon the Premises in violation of this Lease
within 10 days after any such lien is filed against the Premises.

 

(f)         Insolvency
Events. Tenant or any guarantor or surety of Tenant’s obligations hereunder shall: (A) make a general assignment for
the benefit of creditors; (B) commence any case, proceeding or other action seeking to have an order for relief entered on its
behalf as a debtor or to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, liquidation,
dissolution or composition of it or its debts or seeking appointment of a receiver, trustee, custodian or other similar official
for it or for all or of any substantial part of its property (collectively a “Proceeding for Relief”); (C) become
the subject of any Proceeding for Relief which is not dismissed within 90 days of its filing or entry or (D) die or suffer a legal
disability (if Tenant, guarantor, or surety is an individual) or be dissolved or otherwise fail to maintain its legal existence
(if Tenant, guarantor or surety is a corporation, partnership or other entity).

 

(g)         Estoppel
Certificate or Subordination Agreement. Tenant fails to execute any document required from Tenant under Sections 24
or 28 within 5 days after a second notice requesting such document.

 

(h)         Other
Defaults. Tenant shall fail to observe, perform or comply with any provision of this Lease other than those specifically referred
to in this Section 21, and, except as otherwise expressly provided herein, such failure shall continue for a period of 10
days after written notice thereof from Landlord to Tenant.

 

Any notice given under Section 21(h)
hereof shall: (i) specify the alleged default, (ii) demand that Tenant cure such default, (iii) be in lieu of, and not in addition
to, or shall be deemed to be, any notice required under any provision of applicable law, and (iv) not be deemed a forfeiture or
a termination of this Lease unless Landlord elects otherwise in such notice; provided that if the nature of Tenant’s
default pursuant to Section 21(h) is such that it cannot be cured by the payment of money and reasonably requires more than
10 days to cure, then Tenant shall not be deemed to be in default if Tenant commences such cure within said 10 day period and thereafter
diligently prosecutes the same to completion; provided, however, that such cure shall be completed no later than
30 days from the date of Landlord’s notice.

 

22.         Landlord's
Remedies.

 

(a)         Payment
By Landlord; Interest. Upon a Default by Tenant hereunder, Landlord may, without waiving or releasing any obligation of Tenant
hereunder, make such payment or perform such act. All sums so paid or incurred by Landlord, together with interest thereon (from
the date such sums were paid or incurred, at the annual rate (the “Default Rate”) equal to the Prime Rate +
4% (but in no event less than 12% or more than the maximum rate permitted under applicable law)) shall be payable to Landlord on
demand as additional Rent. Nothing herein shall be construed to create or impose a duty on Landlord to mitigate any damages resulting
from Tenant’s Default hereunder. As used herein, the term “Prime Rate” shall mean the highest prime rate
(or base rate) reported in the Money Rates column or section of The Wall Street Journal (Eastern Edition) published from time to
time, as the rate in effect for corporate loans at large U.S. money center commercial banks (whether or not such rate has actually
been charged by any such bank). If The Wall Street Journal ceases publication of the Prime Rate, the “Prime Rate”
shall mean the prime rate (or base rate) announced by Citibank, N.A., New York, New York (whether or not such rate has actually
been charged by such bank). If such bank discontinues the practice of announcing the Prime Rate, the “Prime Rate”
shall mean the highest rate charged by such bank on short-term, unsecured loans to its most creditworthy large corporate borrowers.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 22

    

 

(b)        Late
Payment Rent. Late payment by Tenant to Landlord of Rent and other sums due will cause Landlord to incur costs not contemplated
by this Lease, the exact amount of which will be extremely difficult and impracticable to ascertain. Such costs include, but are
not limited to, processing and accounting charges and late charges which may be imposed on Landlord under any Mortgage covering
the Premises. Therefore, if any installment of Rent due from Tenant is not received by Landlord within 5 days after the date such
payment is due, Tenant shall pay to Landlord an additional sum of 6% of the overdue Rent as a late charge. The parties agree that
this late charge represents a fair and reasonable estimate of the costs Landlord will incur by reason of late payment by Tenant.
In addition to the late charge, Rent not paid when due and remaining unpaid on the 5th day after it first became due
shall bear interest at the Default Rate from the date it first became due until paid.

 

(c)         Remedies.
Upon and during the continuance of a Default, Landlord, at its option, without further notice or demand to Tenant, shall have in
addition to all other rights and remedies provided in this Lease, at law or in equity, the option to pursue any one or more of
the following remedies, each and all of which shall be cumulative and nonexclusive, without any notice or demand whatsoever. No
cure, in whole or in part, of such Default by Tenant after Landlord has taken any action (beyond giving Tenant notice of such Default)
to pursue any remedy provided for herein (including retaining counsel to file an action or otherwise pursue any remedies) shall
in any way affect Landlord’s right to pursue such remedy or any other remedy provided Landlord herein or under law or in
equity, unless Landlord, in its sole discretion, elects to waive such Default.

 

(i)          This
Lease and the Term and estate hereby granted are subject to the limitation that whenever a Default shall have happened and be continuing,
Landlord shall have the right, at its election, then or thereafter while any such Default shall continue and notwithstanding the
fact that Landlord may have some other remedy hereunder or at law or in equity, to give Tenant written notice of Landlord’s
intention to terminate this Lease on a date specified in such notice, which date shall be not less than 5 days after the giving
of such notice, and upon the date so specified, this Lease and the estate hereby granted shall expire and terminate with the same
force and effect as if the date specified in such notice were the date hereinbefore fixed for the expiration of this Lease, and
all right of Tenant hereunder shall expire and terminate, and Tenant shall be liable as hereinafter in this Section 22(c)
provided. If any such notice is given, Landlord shall have, on such date so specified, the right of re-entry and possession of
the Premises and the right to remove all persons and property therefrom and to store such property in a warehouse or elsewhere
at the risk and expense, and for the account, of Tenant. Should Landlord elect to re-enter as herein provided or should Landlord
take possession pursuant to legal proceedings or pursuant to any notice provided for by law, Landlord may from time to time re-let
the Premises or any part thereof for such term or terms and at such rental or rentals and upon such terms and conditions as Landlord
may deem advisable, with the right to make commercially reasonable alterations in and repairs to the Premises.

 

(ii)         In
the event of any termination of this Lease as in this Section 22 provided or as required or permitted by law or in equity,
Tenant shall forthwith quit and surrender the Premises to Landlord, and Landlord may, without further notice, enter upon, re-enter,
possess and repossess the same by summary proceedings, ejectment or otherwise, and again have, repossess and enjoy the same as
if this Lease had not been made, and in any such event neither Tenant nor any person claiming through or under Tenant by virtue
of any law or an order of any court shall be entitled to possession or to remain in possession of the Premises. Landlord, at its
option, notwithstanding any other provision of this Lease, shall be entitled to recover from Tenant, as and for liquidated damages,
the sum of;

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 23

    

 

(A)         all
Base Rent, Additional Rent and other amounts payable by Tenant hereunder then due or accrued and unpaid: and

 

(B)         the
amount equal to the aggregate of all unpaid Base Rent and Additional Rent which would have been payable if this Lease had not been
terminated prior to the end of the Term then in effect, discounted to its then present value in accordance with accepted financial
practice using a rate of 5% per annum, for loss of the bargain; and

 

(C)         all
other damages and expenses (including attorneys’ fees and expenses), if any, which Landlord shall have sustained by reason
of the breach of any provision of this Lease; less

 

(D)         the
net proceeds of any re-letting actually received by Landlord.

 

(iii)        Nothing
herein contained shall limit or prejudice the right of Landlord, in any bankruptcy or insolvency proceeding, to prove for and obtain
as liquidated damages by reason of such termination an amount equal to the maximum allowed by any bankruptcy or insolvency proceedings,
or to prove for and obtain as liquidated damages by reason of such termination, an amount equal to the maximum allowed by any statute
or rule of law whether such amount shall be greater or less than the excess referred to above.

 

(iv)        Nothing
in this Section 22 shall be deemed to affect the right of either party to indemnifications pursuant to this Lease.

 

(v)         If
Landlord terminates this Lease upon the occurrence of a Default, Tenant will quit and surrender the Premises to Landlord or its
agents, and Landlord may, without further notice, enter upon, re-enter and repossess the Premises by summary proceedings, ejectment
or otherwise. The words “enter”, “re-enter”, and “re-entry” are not restricted to their technical
legal meanings.

 

(vi)        If
either party shall be in default in the observance or performance of any provision of this Lease, and an action shall be brought
for the enforcement thereof in which it shall be determined that such party was in default, the party in default shall pay to the
other all fees, costs and other expenses which may become payable as a result thereof or in connection therewith, including attorneys’
fees and expenses.

 

(vii)       If
Tenant shall default in the keeping, observance or performance of any covenant, agreement, term, provision or condition herein
contained, Landlord, without thereby waiving such default, may perform the same for the account and at the expense of Tenant (a)
immediately or at any time thereafter and without notice in the case of emergency or in case such default will result in a violation
of any legal or insurance requirements, or in the imposition of any lien against all or any portion of the Premises, and (b) in
any other case if such default continues after any applicable cure period provided in Section 21. All reasonable costs and
expenses incurred by Landlord in connection with any such performance by it for the account of Tenant and all reasonable costs
and expenses, including attorneys’ fees and disbursements incurred by Landlord in any action or proceeding (including any
summary dispossess proceeding) brought by Landlord to enforce any obligation of Tenant under this Lease and/or the right of Landlord
in or to the Premises, shall be paid by Tenant to Landlord within 10 days after demand.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 24

    

 

(viii)      Intentionally
Deleted.

 

(ix)         Nothing
contained in this Lease shall be construed as limiting or precluding the recovery by Landlord against Tenant of any sums or damages
to which, in addition to the damages particularly provided above, Landlord may lawfully be entitled by reason of any default hereunder
on the part of Tenant. Anything in this Lease to the contrary notwithstanding, during the continuation of any default by Tenant,
Tenant shall not be entitled to exercise any rights or options, or to receive any funds or proceeds being held, under or pursuant
to this Lease.

 

(x)          Tenant
waives and surrenders all right and privilege that Tenant might have under or by reason of any present or future law to redeem
the Premises or to have a continuance of this Lease after Tenant is dispossessed or ejected therefrom by process of law or under
the terms of this Lease or after any termination of this Lease. Tenant also waives the provisions of any law relating to notice
and/or delay in levy of execution in case of any eviction or dispossession for nonpayment of rent, and the provisions of any successor
or other law of like import. 

 

(xi)         Except
as otherwise provided in this Section 22, no right or remedy herein conferred upon or reserved to Landlord is intended to
be exclusive of any other right or remedy, and every right and remedy shall be cumulative and in addition to any other legal or
equitable right or remedy given hereunder, or now or hereafter existing. No waiver of any provision of this Lease shall be deemed
to have been made unless expressly so made in writing. Landlord shall be entitled, to the extent permitted by law, to seek injunctive
relief in case of the violation, or attempted or threatened violation, of any provision of this Lease, or to seek a decree compelling
observance or performance of any provision of this Lease, or to seek any other legal or equitable remedy. 

 

(xii)        Landlord
may continue to collect Rent as the same becomes due without terminating this Lease and without waiving any other rights or remedies
Landlord may have.

 

(xiii)       Anything
contained herein to the contrary notwithstanding, if any termination of this Lease shall be stayed by order of any court having
jurisdiction over any proceeding related to an insolvency event described herein, or by federal or state statute, then, following
the expiration of any such stay, or if the trustee appointed in any such proceeding, Tenant or Tenant as debtor-in-possession shall
fail to assume Tenant's obligations under this Lease within the period prescribed therefor by law (or within 90 days after entry
of the order for relief if no such period is prescribed by law) or such other period as may be allowed by the court, or if said
trustee, Tenant or Tenant as debtor-in-possession shall fail to provide adequate protection of Landlord's right, title and interest
in and to the Premises or adequate assurance of the complete and continuous future performance of Tenant's obligations under this
Lease, Landlord, to the extent permitted by law or by leave of the court having jurisdiction over such proceeding, shall have the
right, at its election, to terminate this Lease on 5 days' notice to Tenant, Tenant as debtor-in-possession or said trustee and
upon the expiration of said 5 day period this Lease shall cease and expire as aforesaid and Tenant, Tenant as debtor-in-possession
or said trustee shall promptly quit and surrender the Premises as aforesaid.

 

(xiv)      Except
as expressly provided herein, none of Landlord or any Landlord Party shall be liable for consequential damages hereunder.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 25

    

 

23.         Assignment
and Subletting.

 

(a)          General
Prohibition. Without Landlord’s prior written consent subject to and on the conditions described in this Section 23,
Tenant shall not, directly or indirectly, voluntarily or by operation of law, assign this Lease or sublease the Premises or any
part thereof or mortgage, pledge, or hypothecate its leasehold interest or grant any concession or license within the Premises,
and any attempt to do any of the foregoing shall be void and of no effect. If Tenant is a corporation, partnership or limited liability
company, the shares or other ownership interests thereof which are not actively traded upon a stock exchange or in the over-the-counter
market, a transfer or series of related or unrelated transfers whereby 25% or more of the issued and outstanding shares or other
direct or indirect ownership interests of such corporation, partnership or limited liability company are, or voting control is,
transferred (but excepting transfers upon deaths of individual owners) from a person or persons or entity or entities which were
owners thereof at the time of execution of this Lease to persons or entities who were not owners of at least the same percentage
of the shares or other ownership interests of the corporation, partnership or limited liability company at the time of execution
of this Lease, shall be deemed an assignment of this Lease requiring the consent of Landlord as provided in this Section 23.
Notwithstanding the foregoing, any public offering of shares or other ownership interest in Tenant shall not be deemed an assignment.

 

(b)          If
this Lease is assigned to any person or entity pursuant to the provisions of 11 U.S.C. Section 101 et seq., or any
successor statute (the “Bankruptcy Code”), any and all monies or other consideration payable or otherwise to
be delivered in connection with such assignment shall be paid or delivered to Landlord, shall be and remain the exclusive property
of Landlord and shall not constitute property of Tenant or of the estate of Tenant within the meaning of the Bankruptcy Code. Any
and all monies or other consideration constituting Landlord's property under the preceding sentence not paid or delivered to Landlord
shall be held in trust for the benefit of Landlord and shall be promptly paid to or turned over to Landlord.

 

(c)          If
Tenant desires to assign, hypothecate or otherwise transfer this Lease or to sublet the Premises, then at least 15 business days,
but not more than 45 business days, before the date Tenant desires the assignment or sublease to be effective (the “Assignment
Date”), Tenant shall give Landlord a notice (the “Assignment Notice”) containing such information
about the proposed assignee or sublessee, including the proposed use of the Premises and any Hazardous Materials proposed to be
used, stored, handled, treated, generated in or released or disposed of from the Premises, the Assignment Date, any relationship
between Tenant and the proposed assignee or sublessee, and all material terms and conditions of the proposed assignment or sublease,
including a copy of the proposed assignment or sublease in its final form, and such other information as Landlord may deem reasonably
necessary or appropriate to its consideration as to whether to grant its consent. Landlord may, by giving written notice to Tenant
within 15 business days after receipt of the Assignment Notice: (i) grant such consent, (ii) refuse such consent, in its sole and
absolute discretion, if (A) the proposed assignment, hypothecation or other transfer or subletting concerns more than (together
with all other then effective subleases) 50% of the Premises or (B) the proposed assignee or subtenant is a tenant of the Project
or any other property owned (in whole or in part) or managed by Landlord or an subsidiary or affiliate of Landlord or any other
Person that has, within the 6 months prior, initiated negotiations with Landlord regarding, or toured (or made an appointment to
tour) the Project with a view to, letting any portion of the Project, (iii) refuse such consent, in its reasonable discretion,
if the proposed subletting concerns (together with all other then effective subleases) 50% or less of the Premises (provided that
Landlord shall further have the right to review and approve or disapprove the proposed form of sublease prior to the effective
date of any such subletting), (iv) sublease such portion of the Premises from the Tenant on the terms described in the Assignment
Notice., or (v) terminate this Lease with respect to the space described in the Assignment Notice as of the Assignment Date (an
“Assignment Termination”). If Landlord delivers notice of its election to exercise an Assignment Termination,
Tenant shall have the right to withdraw such Assignment Notice by written notice to Landlord of such election within 5 business
days after Landlord’s notice electing to exercise the Assignment Termination. If Tenant withdraws such Assignment Notice,
this Lease shall continue in full force and effect. If Tenant does not withdraw such Assignment Notice, this Lease, and the term
and estate herein granted, shall terminate as of the Assignment Date with respect to the space described in such Assignment Notice.
No failure of Landlord to exercise any such option to terminate this Lease, or to deliver a timely notice in response to the Assignment
Notice, shall be deemed to be Landlord’s consent to the proposed assignment, sublease or other transfer. Tenant shall reimburse
Landlord for all of Landlord’s reasonable out-of-pocket expenses in connection with its consideration of any Assignment Notice.
Any Person to which this Lease is assigned pursuant to the provisions of the Bankruptcy Code shall be deemed without further act
or deed to have assumed all of the obligations arising under this Lease on and after the date of such assignment. 

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 26

    

 

(d)         If
Tenant assumes this Lease and proposes to assign the same pursuant to the provisions of the Bankruptcy Code to any Person who shall
have made a bona fide offer to accept an assignment of this Lease on terms acceptable to Tenant, then notice of such
proposed assignment shall be given to Landlord by Tenant no later than 20 days after receipt by Tenant, but in any event no later
than 10 days prior to the date that Tenant shall make application to a court of competent jurisdiction for authority and approval
to enter into such assignment and assumption. Such notice shall set forth (i) the name and address of such Person, (ii) all
of the terms and conditions of such offer, and (iii) adequate assurance of future performance by such Person under the Lease
as set forth below, including, without limitation, the assurance referred to in Section 365(b)(3) of the Bankruptcy Code.
Landlord shall have the prior right and option, to be exercised by notice to Tenant given at any time prior to the effective date
of such proposed assignment, to accept an assignment of this Lease upon the same terms and conditions and for the same consideration,
if any, as the bona fide offer made by such Person, less any brokerage commissions which would otherwise be payable by Tenant
out of the consideration to be paid by such Person in connection with the assignment of this Lease.

 

(e)         The
term “adequate assurance of future performance” as used in this Lease shall mean that any proposed assignee shall,
among other things, (i) deposit with Landlord on the assumption of this Lease a sum equal to 12 monthly installments of the
then Base Rent as security for the faithful performance and observance by such assignee of the terms and obligations of this Lease,
(ii) furnish Landlord with financial statements of such assignee for the prior 3 fiscal years, as finally determined after
an audit and certified as correct by a certified public accountant, which financial statements shall show (A) net annual operating
income of at least 8 times the then annual Base Rent for each of such 3 years and (B) a net worth of at least 10 times the aggregate
Base Rent payable during the remaining term of the Lease, (iii) grant to Landlord a security interest in such property of
the proposed assignee as Landlord shall deem necessary to secure such assignee's future performance under this Lease, and (iv) provide
such other information or take such action as Landlord, in its reasonable judgment shall determine is necessary to provide adequate
assurance of the performance by such assignee of its obligations under this Lease.

 

(f)         If,
at any time after the originally named Tenant herein may have assigned Tenant's interest in this Lease, this Lease shall be disaffirmed
or rejected in any insolvency proceeding of the types described herein, or in any similar proceeding, or in the event of termination
of this Lease by reason of any such proceeding or by reason of lapse of time following notice of termination based upon any Event
of Default, each prior Tenant, including, without limitation, the originally named Tenant, upon request of Landlord given within
30 days next following any such disaffirmance, rejection or termination (and actual notice thereof to Landlord in the event of
a disaffirmance or rejection or in the event of termination other than by act of Landlord), shall (i) pay to Landlord all
Fixed Rent and other items of Rental due and owing by the assignee to Landlord under this Lease to and including the date of such
disaffirmance, rejection or termination, and (ii) as “tenant”, enter into a new lease with Landlord of the Premises
for a term commencing on the effective date of such disaffirmance, rejection or termination and ending on the Expiration Date,
unless sooner terminated as in such lease provided, at the same Fixed Rent and upon the then executory terms, covenants and conditions
as are contained in this Lease, except that (A) Tenant's rights under the new lease shall be subject to the possessory rights
of the assignee under this Lease and the possessory rights of any person claiming through or under such assignee or by virtue of
any statute or of any order of any court, (B) such new lease shall require that Tenant shall cure all defaults existing under
this Lease with due diligence, and (C) such new lease shall require Tenant to pay all items of Rental reserved in this Lease
which, had this Lease not been so disaffirmed, rejected or terminated, would have accrued after the date of such disaffirmance,
rejection or termination with respect to any period prior thereto. If any such prior Tenant shall default in its obligation to
enter into said new lease for a period of 10 days next following Landlord's request therefor, then, in addition to all other rights
and remedies by reason of such default, either at law or in equity, Landlord shall have the same rights and remedies against such
Tenant as if such Tenant had entered into such new lease and such new lease had thereafter been terminated as of the commencement
date thereof by reason of such Tenant's default thereunder.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 27

    

 

(g)          Additional
Conditions. As a condition to any such assignment or subletting, whether or not Landlord’s consent is required, Landlord
may require:

 

(i)          that
any assignee or subtenant agree, in writing at the time of such assignment or subletting, that if Landlord gives such party notice
that Tenant is in default under this Lease, such party shall thereafter make all payments otherwise due Tenant directly to Landlord,
which payments will be received by Landlord without any liability except to credit such payment against those due under this Lease,
and any such third party shall agree to attorn to Landlord or its successors and assigns should this Lease be terminated for any
reason; provided, however, in no event shall Landlord or its successors or assigns be obligated to accept such attornment;

 

(ii)         a
list of Hazardous Materials, certified by the proposed assignee or sublessee to be true and correct, which the proposed assignee
or sublessee intends to use, store, handle, treat, generate in, release or dispose of from the Premises, together with copies of
all documents relating to such use, storage, handling, treatment, generation, release or disposal of Hazardous Materials by the
proposed assignee or subtenant in the Premises or on the Project, prior to the proposed assignment or subletting, including, without
limitation: permits; approvals; reports and correspondence; storage and management plans; plans relating to the installation of
any storage tanks to be installed in or under the Project (provided, said installation of tanks shall only be permitted after Landlord
has given its written consent to do so, which consent may be withheld in Landlord’s sole and absolute discretion); and all
closure plans or any other documents required by any and all federal, state and local Governmental Authorities for any storage
tanks installed in, on or under the Project for the closure of any such tanks. Neither Tenant nor any such proposed assignee or
subtenant is required, however, to provide Landlord with any portion(s) of such documents containing information of a proprietary
nature which, in and of themselves, do not contain a reference to any Hazardous Materials or hazardous activities;

 

(iii)        that
the originally named Tenant herein reaffirm its continuing primary liability under this Lease; and

 

(iv)        that
the assignee or subtenant remake the representations and warranties of Tenant hereunder as of the effective date of such assignment
or subletting.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 28

    

 

(h)          No
Release of Tenant, Sharing of Excess Rents. Notwithstanding any assignment or subletting, Tenant and any guarantor or surety
of Tenant’s obligations under this Lease shall at all times remain fully and primarily responsible and liable for the payment
of Rent and for compliance with all of Tenant’s other obligations under this Lease. If the Rent due and payable by a sublessee
or assignee (or a combination of the rental payable under such sublease or assignment plus any bonus or other consideration therefor
or incident thereto in any form) exceeds the rental payable under this Lease, (excluding however, any Rent payable under this Section
23), then Tenant shall be bound and obligated to pay Landlord as Additional Rent hereunder 50% of such Excess Rent within 10
days following receipt thereof by Tenant. If Tenant shall sublet the Premises or any part thereof, Tenant hereby immediately and
irrevocably assigns to Landlord, as security for Tenant’s obligations under this Lease, all rent from any such subletting,
and Landlord as assignee and as attorney-in-fact for Tenant, or a receiver for Tenant appointed on Landlord’s application,
may collect such rent and apply it toward Tenant’s obligations under this Lease; except that, until the occurrence of a Default,
Tenant shall have the right to collect such rent.

 

(i)          No
Waiver. The consent by Landlord to an assignment or subletting shall not relieve Tenant or any assignees of this Lease or any
sublessees of the Premises from obtaining the consent of Landlord to any further assignment or subletting nor shall it release
Tenant or any assignee or sublessee of Tenant from full and primary liability under this Lease. The acceptance of Rent hereunder,
or the acceptance of performance of any other term, covenant, or condition thereof, from any other person or entity shall not be
deemed to be a waiver of any of the provisions of this Lease or a consent to any subletting, assignment or other transfer of the
Premises.

 

(j)          Prior
Conduct of Proposed Transferee. Notwithstanding any other provision of this Section 23, if (i) the proposed assignee
or sublessee of Tenant has been required by any prior landlord, lender or Governmental Authority to take remedial action in connection
with Hazardous Materials contaminating a property, where the contamination resulted from such party’s action or use of the
property in question, (ii) the proposed assignee or sublessee is subject to an enforcement order issued by any Governmental Authority
in connection with the use, storage, handling, treatment, generation, release or disposal of Hazardous Materials (including, without
limitation, any order related to the failure to make a required reporting to any Governmental Authority), or (iii) the risk that
Landlord would be targeted as a responsible party in connection with the remediation of any pre-existing environmental condition
in the vicinity of or underlying the Project would be materially increased or exacerbated by the proposed use of Hazardous Materials
by such proposed assignee or sublessee, Landlord shall have the absolute right to refuse to consent to any assignment or subletting
to any such party. 

 

24.         Estoppel
Certificate. Tenant shall, within 10 business days of written notice from Landlord, execute, acknowledge and deliver a statement
in writing in any form reasonably requested by a proposed lender or purchaser, (i) certifying that this Lease is unmodified and
in full force and effect (or, if modified, stating the nature of such modification and certifying that this Lease as so modified
is in full force and effect) and the dates to which the rental and other charges are paid in advance, if any, (ii) acknowledging
that there are not any uncured defaults on the part of Landlord hereunder, or specifying such defaults if any are claimed, and
(iii) setting forth such further information with respect to the status of this Lease or the Premises as may be requested thereon.
Any such statement may be relied upon by any prospective purchaser or encumbrancer of all or any portion of the real property of
which the Premises are a part. Tenant’s failure to deliver such statement within such time shall, at the option of Landlord,
be conclusive upon Tenant that the Lease is in full force and effect and without modification except as may be represented by Landlord
in any certificate prepared by Landlord and delivered to Tenant for execution. 

 

25.         Quiet
Enjoyment. So long as Tenant shall perform all of the covenants and agreements herein required to be performed by Tenant, Tenant
shall, subject to the terms of this Lease and the Superior Instruments, at all times during the Term, have peaceful and quiet enjoyment
of the Premises against any person claiming by, through or under Landlord.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 29

    

 

26.         Prorations.
All prorations required or permitted to be made hereunder shall be made on the basis of a 360 day year and 30 day months.

 

27.         Rules
and Regulations. Tenant shall, at all times during the Term and any extension thereof, comply with all reasonable rules and
regulations at any time or from time to time established by Landlord covering use of the Premises and the Project (the “Rules
and Regulations”). The current Rules and Regulations are attached hereto as Exhibit E. If there is any conflict
between said Rules and Regulations and other provisions of this Lease, the terms and provisions of this Lease shall control. Landlord
shall not have any liability or obligation for the breach of any Rules or Regulations by other tenants in the Project and shall
not enforce such Rules and Regulations in a discriminatory manner.

 

28.         Subordination.

 

(a)          The
following capitalized terms, whenever used in this Lease, shall have the respective meanings ascribed to such terms as follows:
(i) “Superior Instruments” shall mean each of the Ground Lease, the IDA Lease Documents, and any Superior Lease
or Mortgage, the Operating Agreement (as defined in the Ground Lease) and all matters to which any of the foregoing are subordinate;
(ii) “Ground Lease” shall mean that certain Agreement of Lease, dated as of December 29, 2006, between New York
City Health and Hospitals Corporation, a New York not-for-profit corporation, as landlord, and Landlord, as tenant, entered into
in respect of the Project and as the same may be further amended or otherwise modified; (iii) “Ground Landlord”
shall mean the then landlord under the Ground Lease; (iv) “IDA Lease Documents” shall mean, collectively, (A)
that certain IDA Lease Agreement between Landlord, as landlord, and The New York City Industrial Development Agency (“IDA”),
as tenant, dated as of December 1, 2006, entered into in respect of the Project and as the same may be further amended or otherwise
modified, and (B) that certain Lease Agreement (the “IDA Lease”), between IDA, as landlord, and Landlord as
tenant, dated as of December 1, 2006 entered into in respect of the Project and as the same may be further amended or otherwise
modified; (v) “Superior Leases” shall mean the leases to which this Lease is subject and subordinate; (vi) “Superior
Lessor” shall mean the lessor under a Superior Lease; (vii) “Superior Party” shall mean each of the
Ground Landlord, any Superior Lessor, any Mortgagee and the City of New York; (viii) “Mortgage” shall mean any
mortgage, deed of trust, security assignment and other encumbrance; and (ix) “Mortgagee” shall mean the Holder
or Holders (including the agent for any lending syndicate) of a Mortgage and shall be deemed to include the beneficiary under a
deed of trust.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 30

    

 

(b)          This
Lease and Tenant’s interest and rights hereunder are hereby made and shall be subject and subordinate at all times to the
Superior Instruments and to the lien of any Mortgage now existing or hereafter created on or against the Project or the Premises,
and all amendments, restatements, renewals, modifications, consolidations, refinancing, assignments and extensions thereof, without
the necessity of any further instrument or act on the part of Tenant; provided, however that so long as there is
no Default hereunder, Tenant’s right to possession of the Premises shall not be disturbed by the Holder of any such Mortgage.
Tenant agrees, at the election of the Holder of any such Mortgage, to attorn to any such Holder substantially in the form set forth
in Exhibit I attached hereto. Tenant agrees upon demand to execute, acknowledge and deliver such instruments, confirming
such subordination, and such instruments of attornment as shall be requested by any such Holder, provided any such instruments
contain appropriate non-disturbance provisions assuring Tenant’s quiet enjoyment of the Premises as set forth in Section
25 hereof. Tenant hereby appoints Landlord attorney in fact for Tenant irrevocably (such power being coupled with an interest)
to execute, acknowledge and deliver any such instrument and instruments for and in the name of Tenant and to cause any such instrument
to be recorded. Notwithstanding the foregoing, any such Holder may at any time subordinate its Mortgage to this Lease, without
Tenant’s consent, by notice in writing to Tenant, and thereupon this Lease shall be deemed prior to such Mortgage without
regard to their respective dates of execution, delivery or recording and in that event such Holder shall have the same rights with
respect to this Lease as though this Lease had been executed prior to the execution, delivery and recording of such Mortgage and
had been assigned to such Holder. If (i) in connection with obtaining financing for or condominiumizing
of the Project, or of any Superior Lease, a banking, insurance or other Superior Party shall request reasonable modifications in
this Lease as a condition to such financing or condominiumizing and/or (ii) the provisions of any Superior Instruments require
Tenant to deliver any instruments or acknowledgements, Tenant will not unreasonably withhold its consent thereto and/or unreasonably
condition or delay the delivery thereof, as the case may be, provided that such modifications and/or instruments or acknowledgements,
in either instance, do not (A) extend or shorten the Term, (B) reduce the usable area of the Premises, (C) increase the Base Rent
or any Additional Rent (D) except to a de minimis extent, otherwise increase the obligations of Tenant or the rights of Landlord
under this Lease or (E) except to a de minimis extent, otherwise decrease the obligations of Landlord or the rights of Tenant under
this Lease. At Ground Landlord's option, on the termination of the Ground Lease pursuant to an event of default by Landlord as
the tenant thereunder, the Tenant shall attorn to, or shall enter into a direct lease on terms identical to the Lease with, Ground
Landlord for the balance of the unexpired term of this Lease.

 

(c)          By
its execution and delivery of this Lease, Tenant expressly acknowledges and agrees that it shall comply, and cause its agents,
employees, contractors, subcontractors, subtenants, operators, licensees, franchisees, concessionaires or other occupants of the
Premises to comply, fully and faithfully at all times, to the extent applicable to the Premises, with all terms, covenants and
conditions of the Superior Instruments of which Tenant has been given notice from time to time and which by their terms are applicable
to a space lease of all or any portion of the Project (collectively, “Tenant’s
Superior Instrument Obligations”), as more particularly described on Exhibit M
attached hereto, such acknowledgment and agreement being a material inducement to Landlord’s
execution and delivery of this Lease and leasing of the Premises to Tenant. Tenant further acknowledges and agrees that, pursuant
to the Ground Lease, any act or omission of Tenant or any of its agents, employees, contractors, subcontractors, subtenants, operators,
licensees, franchisees, concessionaires or other occupants of the Premises that violates any provision of the Ground Lease may
be deemed to be a violation of such provision by Landlord as the tenant under the Ground Lease.

 

(d)          Tenant
acknowledges and agrees that, notwithstanding anything herein to the contrary, Landlord may modify or amend this Lease from time
to time in order to avoid the occurrence of a default under the Superior Instruments, provided such modification or amendment does
not (i) extend or shorten the Term, (ii) reduce the usable area of the Premises, (iii) increase the Base Rent or any Additional
Rent (iv) except to a de minimis extent, otherwise increase the obligations of Tenant or the rights of Landlord under this Lease
or (v) except to a de minimis extent, otherwise decrease the obligations of Landlord or the rights of Tenant under this Lease.
Tenant shall promptly execute any such modification or amendment to this Lease.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 31

    

 

29.         Surrender.

 

(a)          Upon
the expiration of the Term or earlier termination of Tenant’s right of possession, Tenant shall surrender the Premises to
Landlord in the same condition as received, subject to any Alterations or Installations permitted by Landlord to remain in the
Premises, free of Hazardous Materials brought upon, kept, used, stored, handled, treated, generated in, or released or disposed
of from, the Premises by any person other than a Landlord Party (collectively, “Tenant HazMat Operations”) and
with all Hazardous Materials Clearances in place, and in broom clean condition, ordinary wear and tear and casualty loss and condemnation
(which are covered by Sections 19 and 20) excepted. At least 3 months prior to the surrender of the Premises, Tenant
shall deliver to Landlord a narrative description of the actions proposed (or required by any Governmental Authority) to be taken
by Tenant in order to surrender the Premises (including any Installations permitted by Landlord to remain in the Premises) at the
expiration or earlier termination of the Term, free from any residual impact from the Tenant HazMat Operations and otherwise released
for unrestricted use and occupancy (the “Surrender Plan”). Such Surrender Plan shall be accompanied by a current
listing of (i) all Hazardous Materials licenses and permits held by or on behalf of any Tenant Party with respect to the Premises,
and (ii) all Hazardous Materials used, stored, handled, treated, generated, released or disposed of from the Premises, and shall
be subject to the review and approval of Landlord’s environmental consultant. In connection with the review and approval
of the Surrender Plan, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such additional non-proprietary
information concerning Tenant HazMat Operations as Landlord shall request. On or before such surrender, Tenant shall deliver to
Landlord evidence that the approved Surrender Plan shall have been satisfactorily completed and Landlord shall have the right to
cause Landlord’s environmental consultant to inspect the Premises and perform such additional procedures as may be deemed
reasonably necessary to confirm that the Premises are, as of the effective date of such surrender or early termination of this
Lease, free from any residual impact from Tenant HazMat Operations. Landlord shall have the unrestricted right to deliver such
Surrender Plan and any report by Landlord’s environmental consultant with respect to the surrender of the Premises to third
parties. 

 

(b)          If
Tenant shall fail to prepare or submit a Surrender Plan approved by Landlord, or if Tenant shall fail to complete the approved
Surrender Plan, or if such Surrender Plan, whether or not approved by Landlord, shall fail to adequately address any residual effect
of Tenant HazMat Operations in, on or about the Premises, such failure shall be deemed a failure to vacate in accordance with this
Lease, and Landlord shall retain all remedies available under this Lease, at law or equity including, without limitation, the right
to collect rent on a holdover basis, and Landlord shall have the right to take such actions as Landlord may deem reasonable or
appropriate to assure that the Premises and the Project are surrendered free from any residual impact from Tenant HazMat Operations,
the cost of which actions shall be reimbursed by Tenant as Additional Rent, without regard to the limitation set forth in the first
paragraph of this Section 29.

 

(c)          Prior
to the expiration of the Term, Tenant shall immediately return to Landlord all keys and/or access cards to parking facilities,
the Project, restrooms or all or any portion of the Premises furnished to or otherwise procured by Tenant. If any such access card
or key is lost, Tenant shall pay to Landlord, at Landlord’s election, either the cost of replacing such lost access card
or key or the cost of reprogramming the access security system in which such access card was used or changing the lock or locks
opened by such lost key. Any Tenant’s Property, Alterations and property not so removed by Tenant as permitted or required
herein shall be deemed abandoned and may be stored, removed, and disposed of by Landlord at Tenant’s expense, and Tenant
waives all claims against Landlord for any damages resulting from Landlord’s retention and/or disposition of such property.
All obligations of Tenant hereunder not fully performed as of the termination of the Term, including the obligations of Tenant
under Section 31 hereof, shall survive the expiration or earlier termination of the Term, including, without limitation,
indemnity obligations, payment obligations with respect to Rent and obligations concerning the condition and repair of the Premises.

 

30.         Waiver
of Jury Trial; Consent to Jurisdiction; Prohibited Parties.

 

(a)          TENANT
AND LANDLORD WAIVE ANY RIGHT TO TRIAL BY JURY OR TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT,
TORT, OR OTHERWISE, BETWEEN LANDLORD AND TENANT ARISING OUT OF THIS LEASE OR ANY OTHER INSTRUMENT, DOCUMENT, OR AGREEMENT EXECUTED
OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED HERETO.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 32

    

 

(b)          Landlord
and Tenant each hereby (i) irrevocably and unconditionally consents and submits to the jurisdiction of any Federal, state, county
or municipal court sitting in the County and State of New York in respect to any action or proceeding concerning any matters arising
out of or in any way relating to this Lease; (ii) irrevocably waives all objections as to venue and any and all rights it may have
to seek a change of venue with respect to any such action or proceedings if the same is brought in the County of New York ; (iii)
agrees that this Lease and the rights and obligations of the parties shall be governed by and construed, and all actions, proceedings
and all controversies and disputes arising under or of or relating to this Lease shall be resolved in accordance with the internal
substantive laws of the State of New York applicable to agreements made and to be wholly performed within the State of New York,
(iv) waives any defense to any action or proceeding granted by the laws of any other country or jurisdiction unless such defense
is also allowed by the laws of the State of New York and (v) agrees that any final judgment rendered against it in any such action
or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the judgment or in any other manner
provided by law. Tenant hereby represents that it is subject to service of process in the State of New York and covenants that
it will remain so subject for the term of this Agreement. If for any reason Tenant should cease to be so subject to service of
process in the State of New York, Tenant hereby designates and appoints Mintz Levin Cohn Ferris Glovsky and Popeo P.C., 666
3rd Avenue, New York, NY 10017, as its agent upon whom may be served all process, pleadings,
notices or other papers which may be served upon Tenant as a result of any of its obligations under this Agreement, and if such
agent shall cease to act or otherwise cease to be subject to service of process in the State of New York, Tenant designates and
appoints the Secretary of State of New York as its agent for service; provided, however, that the serving of such process, pleadings,
notices or other papers shall not constitute a condition to Tenant's obligations hereunder. For the term of this Agreement, Tenant's
agent designated herein shall accept and acknowledge in Tenant's behalf service of any and all process in any such suit, action
or proceeding brought in any such court. Tenant agrees and consents that any such service of process upon such agents and written
notice of such service to the Lessee in the manner set forth herein shall be taken and held to be valid personal service upon Tenant
whether or not Tenant shall then be doing, or at any time shall have done, business within the State of New York and that any such
service of process shall be of the same force and validity as if service were made upon Tenant according to the laws governing
the validity and requirements of such service in the State of New York, and waive all claim of error by reason of any such service.
Such agents shall not have any power or authority to enter into any appearance or to file any pleadings in connection with any
suit, action or other legal proceedings against Tenant or to conduct the defense of any such suit, action or any other legal proceeding
except as expressly authorized by Tenant.

 

(c)          Tenant
represents and warrants to Landlord that (i) it and each Affiliate or Principal directly or indirectly owning an interest in it
is not a Prohibited Entity (as defined in Section 30(d)), (ii) none of the funds or other assets of it constitute property
of, or are beneficially owned, directly or indirectly, by, any Person (as defined in Section 30(d)) on the List (as defined
in Section 30(d)), (iii) no Person on the List has any interest of any nature whatsoever in it (whether directly or indirectly),
and (iv) none of its funds have been derived from any unlawful activity with the result that the investment in it is prohibited
by law or that this Lease is in violation of law. Tenant covenants and agrees (I) to comply with all Legal Requirements relating
to money laundering, anti-terrorism, trade embargos and economic sanctions, now or hereafter in effect, (II) to immediately notify
the other in writing if any of the representations, warranties or covenants set forth in this Section 30(c) are no longer
true or have been breached or if it has a reasonable basis to believe that they may no longer be true or have been breached, (III)
not to use funds from any Person on the List to make any payment due to Landlord under this Lease and (IV) at the request of the
other, to provide such information as may be reasonably requested by Landlord to determine the other’s compliance with the
terms hereof. Tenant hereby acknowledges and agrees that inclusion on the List of Tenant or any Affiliate or Principal of Tenant
at any time during this Lease Term shall be a material default of this Lease. Notwithstanding anything to the contrary contained
herein, Tenant shall not permit the Premises or any portion thereof to be used or occupied by any Person on the List (on a permanent,
temporary or transient basis), and any such use or occupancy of the Premises by any such Person shall be a material default of
this Lease. Notwithstanding anything to the contrary contained in this Section 30(c), so long as Landlord or its ultimate
parent is a company whose capital stock is traded on a recognized public exchange, Landlord makes no representations or warranties
as to the persons or entities owning an interest in Landlord.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 33

    

 

(d)          The
following capitalized terms, whenever used in this Lease, shall have the respective meanings ascribed to such terms as follows:
(i) “Prohibited Entity” shall mean (A) any Prohibited Person or (B) any Person that is identified on the List;
(ii) “Prohibited Person” shall mean (A) any Person (1) that is in default, after notice and beyond the expiration
of any applicable cure period, of such Person’s obligations under any material written agreement with the City, the State
of New York or any of their instrumentalities, or (2) that directly controls, is controlled by, or is under common control with
a Person that is in default, after notice and beyond the expiration of any applicable cure period, of such Person’s obligations
under any material written agreement with the City, the State of New York or any of their instrumentalities, unless, in each instance,
such default or breach either (a) has been waived in writing by the City, the State of New York or any of their instrumentalities
as the case may be, or (b) is being disputed in a court of law, administrative proceeding, arbitration or other forum, or (c) is
cured within 30 days after a determination and notice to Tenant from Landlord that such Person is a Prohibited Person as a result
of such default; (B) any Person that is an Organized Crime Figure; (C) any government, or any Person that is directly or indirectly
controlled (rather than only regulated) by a government, that is finally determined to be in violation of (including, but not limited
to, any participant in an international boycott in violation of) the Export Administration Act of 1979, as amended, or any successor
statute, or the regulations issued pursuant thereto, or any government that is, or any Person that, directly or indirectly, is
controlled (rather than only regulated) by a government that is subject to the regulations or controls thereof; (D) any government,
or any Person that, directly or indirectly, is controlled (rather than only regulated) by a government, the effects or the activities
of which are regulated or controlled pursuant to regulations of the United States Treasury Department or executive orders of the
President of the United States of America issued pursuant to the Trading with the Enemy Act of 1917, as amended; (E) any Person
that is in default in the payment to the City of any real estate taxes, sewer rents or water charges totaling more than $10,000,
unless such default is then being contested in good faith in accordance with applicable Legal Requirements or unless such default
is cured within 30 days after a determination and notice to Tenant from Landlord that such Person is a Prohibited Person as a result
of such default; or (F) any Person (1) that has solely owned, at any time during the 3-year period immediately preceding a determination
of whether such Person is a Prohibited Person, any property which, while in the ownership of such Person, was acquired by the City
by in rem tax foreclosure, other than a property in which the City has released or is in the process of releasing its interest
pursuant to the Administrative Code of the City, or (2) that, directly or indirectly controls, is controlled by, or is under common
control with a Person that has owned, at any time in the 3-year period immediately preceding a determination of whether such Person
is a Prohibited Person, any property which, while in the ownership of such Person, was acquired by the City by in rem tax foreclosure,
other than a property in which the City has released or is in the process of releasing its interest to such Person pursuant to
the Administrative Code of the City; (iii) “Organized Crime Figure” shall mean any Person (A) who has been convicted
in a criminal proceeding for a felony or any crime involving moral turpitude or that is an organized crime figure or is reputed
to have substantial business or other affiliations with an organized crime figure, or (B) who, directly or indirectly controls,
is controlled by, or is under common control with, a Person who has been convicted in a criminal proceeding for a felony or any
crime involving moral turpitude or that is an organized crime figure or is reputed to have substantial business or other affiliations
with an organized crime figure; and, the determination as to whether any Person is an organized crime figure or is reputed to have
substantial business or other affiliations with an organized crime figure shall be within the sole discretion of Landlord, which
discretion shall be exercised in good faith, or as determined by the Ground Landlord in accordance with the terms of the Ground
Lease; (iv) “Person” shall mean (A) an individual, corporation, limited liability company, partnership, joint
venture, estate, trust, unincorporated association or other business entity, (B) any federal, state, county or municipal government
(or any bureau, department, agency or instrumentality thereof), and (C) any fiduciary acting in such capacity on behalf of any
of the foregoing; (v) “List” shall mean, collectively, as updated from time to time, the Specially Designated
Nationals and Blocked Persons List maintained by the Office of Foreign Assets Control of the Department of the Treasury (“OFAC”)
and/or on any other similar list maintained by OFAC pursuant to any authorizing statute, executive order or regulation; and (vi)
“Principal” shall mean, in respect of Tenant, any Person that is a direct or indirect owner of an equity interest
in Tenant.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 34

    

 

31.         Environmental
Requirements.

 

(a)          Prohibition/Compliance/Indemnity.
Tenant shall not cause or permit any Hazardous Materials (as hereinafter defined) to be brought upon, kept, used, stored, handled,
treated, generated in or about, or released or disposed of from, the Premises or the Project in violation of applicable Environmental
Requirements (as hereinafter defined) by Tenant or any Tenant Party. If Tenant breaches the obligation stated in the preceding
sentence, or if the presence of Hazardous Materials in the Premises during the Term or any holding over results in contamination
of the Premises, the Project or any adjacent property, or if contamination of the Premises, the Project or any adjacent property
by Hazardous Materials brought into, kept, used, stored, handled, treated, generated in or about, or released or disposed of from,
the Premises by anyone other than Landlord and Landlord’s employees, agents and contractors otherwise occurs during the Term
or any holding over, Tenant hereby indemnifies and shall defend and hold Landlord, its officers, directors, employees, agents and
contractors harmless from any and all actions (including, without limitation, remedial or enforcement actions of any kind, administrative
or judicial proceedings, and orders or judgments arising out of or resulting therefrom), costs, claims, damages (including, without
limitation, punitive damages and damages based upon diminution in value of the Premises or the Project, or the loss of, or restriction
on, use of the Premises or any portion of the Project), expenses (including, without limitation, attorneys’, consultants’
and experts’ fees, court costs and amounts paid in settlement of any claims or actions), fines, forfeitures or other civil,
administrative or criminal penalties, injunctive or other relief (whether or not based upon personal injury, property damage, or
contamination of, or adverse effects upon, the environment, water tables or natural resources), liabilities or losses (collectively,
“Environmental Claims”) which arise during or after the Term as a result of such contamination. This indemnification
of Landlord by Tenant includes, without limitation, costs incurred in connection with any investigation of site conditions or any
cleanup, treatment, remedial, removal, or restoration work required by any federal, state or local Governmental Authority because
of Hazardous Materials present in the air, soil or ground water above, on, or under the Premises. Without limiting the foregoing,
if the presence of any Hazardous Materials on the Premises, the Building, the Project or any adjacent property results in any contamination
of the Premises, the Building, the Project or any adjacent property, Tenant shall promptly take all actions at its sole expense
and in accordance with applicable Environmental Requirements as are necessary to return the Premises, the Building, the Project
or any adjacent property to the condition existing prior to the time of such contamination, provided that Landlord’s approval
of such action shall first be obtained, which approval shall not unreasonably be withheld so long as such actions would not potentially
have any material adverse long-term or short-term effect on the Premises , the Building or the Project. 

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 35

    

 

(b)          Business.
As a material inducement to Landlord to allow Tenant to use Hazardous Materials in connection with its business, Tenant agrees
to deliver to Landlord prior to the Commencement Date a list identifying each type of Hazardous Materials to be brought upon, kept,
used, stored, handled, treated, generated on, or released or disposed of from, the Premises and setting forth any and all governmental
approvals or permits required in connection with the presence, use, storage, handling, treatment, generation, release or disposal
of such Hazardous Materials on or from the Premises (“Hazardous Materials List”). Tenant shall deliver to Landlord
an updated Hazardous Materials List at least once a year and shall also deliver an updated list before any new Hazardous Material
is brought onto, kept, used, stored, handled, treated, generated on, or released or disposed of from, the Premises. Tenant shall
deliver to Landlord true and correct copies of the following documents (the “Haz Mat Documents”) relating to
the use, storage, handling, treatment, generation, release or disposal of Hazardous Materials prior to the Commencement Date, or
if unavailable at that time, concurrent with the receipt from or submission to a Governmental Authority: permits; approvals; reports
and correspondence; storage and management plans, notice of violations of any Legal Requirements; and a Surrender Plan (to the
extent surrender in accordance with Section 29 cannot be accomplished in 3 months). Tenant is not required, however, to
provide Landlord with any portion(s) of the Haz Mat Documents containing information of a proprietary nature which, in and of themselves,
do not contain a reference to any Hazardous Materials or hazardous activities. It is not the intent of this Section 31(b)
to provide Landlord with information which could be detrimental to Tenant’s business should such information become possessed
by Tenant’s competitors.

 

(c)          Tenant
Representation and Warranty. Tenant hereby represents and warrants to Landlord that (i) neither Tenant nor any of its legal
predecessors has been required by any prior landlord, lender or Governmental Authority at any time to take remedial action in connection
with Hazardous Materials contaminating a property which contamination was permitted by Tenant of such predecessor or resulted from
Tenant’s or such predecessor’s action or use of the property in question, and (ii) Tenant is not subject to any enforcement
order issued by any Governmental Authority in connection with the use, storage, handling, treatment, generation, release or disposal
of Hazardous Materials (including, without limitation, any order related to the failure to make a required reporting to any Governmental
Authority). If Landlord determines that this representation and warranty was not true as of the date of this lease, Landlord shall
have the right to terminate this Lease in Landlord’s sole and absolute discretion.

 

(d)          Intentionally
Deleted.

 

(e)          Intentionally
Deleted.

 

(f)          Tenant’s
Obligations. Tenant’s obligations under this Section 31 shall survive the expiration or earlier termination of
this Lease. During any period of time after the expiration or earlier termination of this Lease required by Tenant or Landlord
to complete the removal from the Premises of any Hazardous Materials (including, without limitation, the release and termination
of any licenses or permits restricting the use of the Premises and the completion of the approved Surrender Plan), Tenant shall
continue to pay the full Rent in accordance with this Lease attributable to any portion of the Premises not re-let by Landlord
in Landlord’s sole discretion, which Rent shall be prorated daily.

 

(g)          Definitions.
 As used herein, the term “Environmental Requirements” means all applicable present and future statutes,
regulations, ordinances, rules, codes, judgments, orders or other similar enactments of any Governmental Authority regulating or
relating to health, safety, or environmental conditions on, under, or about the Premises or the Project, or the environment, including
without limitation, the following: the Comprehensive Environmental Response, Compensation and Liability Act; the Resource Conservation
and Recovery Act; and all state and local counterparts thereto, and any regulations or policies promulgated or issued thereunder.
As used herein, the term “Hazardous Materials” means and includes any substance, material, waste, pollutant,
or contaminant listed or defined as hazardous or toxic, or regulated by reason of its impact or potential impact on humans, animals
and/or the environment under any Environmental Requirements, asbestos and petroleum, including crude oil or any fraction thereof,
natural gas liquids, liquefied natural gas, or synthetic gas usable for fuel (or mixtures of natural gas and such synthetic gas).
As defined in Environmental Requirements, Tenant is and shall be deemed to be the “operator” of Tenant’s “facility”
and the “owner” of all Hazardous Materials brought on the Premises by Tenant or any Tenant Party, and the wastes, by-products,
or residues generated, resulting, or produced therefrom.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 36

    

 

(h)         Intentionally
Deleted.

 

32.         Tenant’s
Remedies/Limitation of Liability. Landlord shall not be in default hereunder unless Landlord fails to perform any of its obligations
hereunder within 30 days after written notice from Tenant specifying such failure (unless such performance will, due to the nature
of the obligation, require a period of time in excess of 30 days, then after such period of time as is reasonably necessary). Upon
any default by Landlord, Tenant shall give notice by registered or certified mail to any Holder of a Mortgage covering the Premises
and to any landlord of any lease of property in or on which the Premises are located and Tenant shall offer such Holder and/or
landlord a reasonable opportunity to cure the default, including time to obtain possession of the Project by power of sale or a
judicial action if the same should prove necessary to effect a cure; provided Landlord shall have furnished to Tenant in
writing the names and addresses of all such persons who are to receive such notices. All obligations of Landlord hereunder shall
be construed as covenants, not conditions; and, except as may be otherwise expressly provided in this Lease, Tenant may not terminate
this Lease for breach of Landlord’s obligations hereunder. 

 

All obligations of
Landlord under this Lease will be binding upon Landlord only during the period of its ownership of the Premises and not thereafter.
The term “Landlord” in this Lease shall mean only the owner for the time being of the Premises. Upon the transfer
by such owner of its interest in the Premises, such owner shall thereupon be released and discharged from all obligations of Landlord
thereafter accruing, but such obligations shall be binding during the Term upon each new owner for the duration of such owner’s
ownership.

 

33.         Inspection
and Access. Landlord and its agents, representatives, and contractors may enter the Premises at any reasonable time to inspect
the Premises and to make such repairs as may be required or permitted pursuant to this Lease and for any other business purpose.
Landlord and Landlord’s representatives may enter the Premises during business hours on not less than 48 hours advance written
notice (except in the case of emergencies in which case no such notice shall be required and such entry may be at any time) for
the purpose of effecting any such repairs, inspecting the Premises, showing the Premises to prospective purchasers and, during
the last year of the Term, to prospective tenants or for any other business purpose. Landlord may erect a suitable sign on the
Premises stating the Premises are available to let or that the Project is available for sale. Landlord may grant easements, make
public dedications, designate Common Areas and create restrictions on or about the Premises, provided that no such easement,
dedication, designation or restriction materially, adversely affects Tenant’s use or occupancy of the Premises for the Permitted
Use. At Landlord’s request, Tenant shall execute such instruments as may be necessary for such easements, dedications or
restrictions. Tenant shall at all times, except in the case of emergencies, have the right to escort Landlord or its agents, representatives,
contractors or guests while the same are in the Premises, provided such escort does not materially and adversely affect Landlord’s
access rights hereunder.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 37

    

 

34.        Security.
Tenant acknowledges and agrees that security devices and services, if any, while intended to deter crime may not in given instances
prevent theft or other criminal acts and that Landlord is not providing any security services with respect to the Premises. Tenant
agrees that Landlord shall not be liable to Tenant for, and Tenant waives any claim against Landlord with respect to, any loss
by theft or any other damage suffered or incurred by Tenant in connection with any unauthorized entry into the Premises or any
other breach of security with respect to the Premises. Tenant shall be solely responsible for the personal safety of Tenant’s
officers, employees, agents, contractors, guests and invitees while any such person is in, on or about the Premises and/or the
Project. Tenant shall at Tenant’s cost obtain insurance coverage to the extent Tenant desires protection against such criminal
acts. All employees, contractors and/or agents of any provider of security services to the Premises engaged by Tenant shall be
prohibited from carrying firearms (e.g. handguns, rifles, shotguns, etc.). Each individual employee or independent contractor of
any such service provider shall have been registered with Landlord by facsimile or mail at least 48 hours in advance of such person
arriving at the Project to perform service, which registration shall require such personal information and history, and photographs,
as Landlord shall reasonably require.

 

35.        Force
Majeure. Landlord shall not be responsible or liable for delays in the performance of its obligations hereunder when caused
by, related to, or arising out of acts of God, strikes, lockouts, or other labor disputes, vandalism, embargoes, quarantines, weather,
national, regional, or local disasters, calamities, or catastrophes, inability to obtain labor or materials (or reasonable substitutes
therefor) at reasonable costs or failure of, or inability to obtain, utilities necessary for performance, governmental restrictions,
orders, limitations, regulations, or controls, national emergencies, delay in issuance or revocation of permits, enemy or hostile
governmental action, terrorism, insurrection, riots, civil disturbance or commotion, fire or other casualty, and other causes or
events beyond the reasonable control of Landlord (“Force Majeure”).

 

36.        Brokers,
Entire Agreement, Amendment. Landlord and Tenant each represents and warrants that it has not dealt with any broker, agent
or other person (collectively, “Broker”) in connection with this transaction and that no Broker brought about
this transaction. Landlord and Tenant each hereby agree to indemnify and hold the other harmless from and against any claims by
any Broker, other than the broker, if any named in this Section 36, claiming a commission or other form of compensation
by virtue of having dealt with Tenant or Landlord, as applicable, with regard to this leasing transaction.

 

37.        Limitation
on Landlord’s Liability. NOTWITHSTANDING ANYTHING SET FORTH HEREIN OR IN ANY OTHER AGREEMENT BETWEEN LANDLORD AND TENANT
TO THE CONTRARY: (A) LANDLORD SHALL NOT BE LIABLE TO TENANT OR ANY OTHER PERSON FOR (AND TENANT AND EACH SUCH OTHER PERSON ASSUME
ALL RISK OF) LOSS, DAMAGE OR INJURY, WHETHER ACTUAL OR CONSEQUENTIAL TO: TENANT’S PERSONAL PROPERTY OF EVERY KIND AND DESCRIPTION,
INCLUDING, WITHOUT LIMITATION TRADE FIXTURES, EQUIPMENT, INVENTORY, SCIENTIFIC RESEARCH, SCIENTIFIC EXPERIMENTS, LABORATORY ANIMALS,
PRODUCT, SPECIMENS, SAMPLES, AND/OR SCIENTIFIC, BUSINESS, ACCOUNTING AND OTHER RECORDS OF EVERY KIND AND DESCRIPTION KEPT AT THE
PREMISES AND ANY AND ALL INCOME DERIVED OR DERIVABLE THEREFROM; (B) THERE SHALL BE NO PERSONAL RECOURSE TO LANDLORD FOR ANY ACT
OR OCCURRENCE IN, ON OR ABOUT THE PREMISES OR ARISING IN ANY WAY UNDER THIS LEASE OR ANY OTHER AGREEMENT BETWEEN LANDLORD AND TENANT
WITH RESPECT TO THE SUBJECT MATTER HEREOF AND ANY LIABILITY OF LANDLORD HEREUNDER SHALL BE STRICTLY LIMITED SOLELY TO LANDLORD’S
INTEREST IN THE PROJECT OR ANY PROCEEDS FROM SALE OR CONDEMNATION THEREOF AND ANY INSURANCE PROCEEDS PAYABLE IN RESPECT OF LANDLORD’S
INTEREST IN THE PROJECT OR IN CONNECTION WITH ANY SUCH LOSS; AND (C) IN NO EVENT SHALL ANY PERSONAL LIABILITY BE ASSERTED AGAINST
ANY OF LANDLORD’S OFFICERS, DIRECTORS, EMPLOYEES, AGENTS OR CONTRACTORS. UNDER NO CIRCUMSTANCES SHALL LANDLORD OR ANY OF
LANDLORD’S OFFICERS, DIRECTORS, EMPLOYEES, AGENTS OR CONTRACTORS BE LIABLE FOR INJURY TO TENANT’S BUSINESS OR FOR ANY
LOSS OF INCOME OR PROFIT THEREFROM.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 38

    

 

38.         Severability.
If any clause or provision of this Lease is illegal, invalid or unenforceable under present or future laws, then and in that event,
it is the intention of the parties hereto that the remainder of this Lease shall not be affected thereby. It is also the intention
of the parties to this Lease that in lieu of each clause or provision of this Lease that is illegal, invalid or unenforceable,
there be added, as a part of this Lease, a clause or provision as similar in effect to such illegal, invalid or unenforceable clause
or provision as shall be legal, valid and enforceable.

 

39.         Signs;
Exterior Appearance. Tenant shall not, without the prior written consent of Landlord, which may be granted or withheld in Landlord’s
sole discretion: (i) attach any awnings, exterior lights, decorations, balloons, flags, pennants, banners, painting or other projection
to any outside wall of the Project, (ii) use any curtains, blinds, shades or screens other than Landlord’s standard window
coverings, (iii) coat or otherwise sunscreen the interior or exterior of any windows, (iv) place any bottles, parcels, or other
articles on the window sills, (v) place any equipment, furniture or other items of personal property on any exterior balcony, or
(vi) paint, affix or exhibit on any part of the Premises or the Project any signs, notices, window or door lettering, placards,
decorations, or advertising media of any type which can be viewed from the exterior of the Premises. Interior signs on doors and
the directory tablet shall be inscribed, painted or affixed for Tenant by Landlord at the sole cost and expense of Tenant, and
shall be of a size, color and type acceptable to Landlord. Nothing may be placed on the exterior of corridor walls or corridor
doors other than Landlord’s standard lettering. The directory tablet shall be provided exclusively for the display of the
name and location of tenants of the Project.

 

40.         Zoning
Rights. At all times, Landlord shall have the right, and Tenant shall not have the right,
(i) to cause all or any part of the Premises and/or the zoning lot upon which the Building is located in whole or in part (hereinafter
referred to solely for purposes of this Section 40 as the “Land”)
and/or the Building, to be combined with any other land, condominium units or other premises so as to constitute the combined
premises into a single zoning “lot” or “development” or “enlargement” as those terms are now,
or may hereafter be, defined in the Zoning Resolution of The City of New York (the “Zoning Resolution”),
(ii) to cause any lot, development or enlargement at any time constituting or including all or any part of the Premises, the Land
or the Building to be subdivided into two or more lots, developments or enlargements, (iii) to cause development rights (whether
from the Land or other premises) to be transferred to any such lot, development or enlargement, (iv) to cause other combinations,
subdivisions and transfers to be effected, whether similar or dissimilar to those now permitted by law or (v) to exploit, sell,
convey, lease or otherwise transfer any so called “air rights,” “air space,” “zoning rights”
or “development rights” above or appurtenant to the Land and/or the Building provided that and for so long as the
foregoing actions described in clauses (i) through (v) do not (a) adversely affect Tenant or Tenant’s use and enjoyment
of the Premises, (b) increase the Base Rent or any Additional Rent, (c) otherwise increase the obligations of Tenant or the rights
of Landlord under this Lease or (d) otherwise decrease the obligations of Landlord or the rights of Tenant under this Lease. Tenant
hereby acknowledges that it is not a “party in interest” as defined in the Zoning Resolution, and shall not and cannot
become a “party in interest” under any circumstances by virtue of its leasehold interest hereunder. Tenant further
acknowledges that neither Tenant nor the estate or interest of Tenant hereunder would be “adversely affected” (within
the meaning of the Zoning Resolution) by any development of the Land or the Building or any such combined premises nor by the
filing of any declaration combining all or a part of the Land and/or the Building with any other premises and that Tenant’s
estate and interest hereunder are not and would not be superior to any such declaration. Notwithstanding the foregoing, in the
event that Tenant is deemed to have any of the rights disclaimed above, or is deemed to be a party in interest, Tenant hereby
transfers such rights and any rights as a party in interest to Landlord. In furtherance thereof, Tenant will within 3 business
days after written request by Landlord execute and deliver to Landlord a waiver of its right to join in a Declaration of Restrictions
pursuant to Section 12-10 of the Zoning Resolution.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 39

    

 

41.         Excavation.
In the event that an excavation, or any construction, should be undertaken in connection
with the Building or other purposes upon land adjacent to the Building and/or the Project, or should be authorized to be made,
Tenant shall, upon reasonable prior notice, if necessary, afford to the person or persons causing or authorized to cause such
excavation or construction or other purpose, the right, for brief periods of time and in a manner so as to avoid any material
interference with Tenant’s business, subject to such reasonable conditions as Tenant may reasonably impose, to enter upon
the Premises for the purpose of doing such work as shall reasonably be necessary to protect or preserve the wall or walls of the
Building, from injury or damage and to support them by proper foundations, pinning and/or underpinning, or otherwise.

 

42.         Employment
Reporting and Requirements.

 

(a)          With
regard to each annual period from July 1 through June 30 upon written request by Landlord, Tenant shall complete with regard to
itself and any of its subtenants, items 1-5, 15 and 16 of the Employment and Benefits Report (with the dates therein updated to
reflect the applicable Fiscal Year) attached as Exhibit P
to the Ground Lease, and Tenant shall sign such report and submit it to Landlord before July 15 immediately following such annual
period; and 

 

(b)          Tenant
shall, in good faith, consider such proposals as the City and/or City-related entities may make with regard to any jobs Tenant
may seek to fill in relation to its activities on or concerning the Premises, and shall provide the City and such entities with
the opportunity to (A) refer candidates who are City residents having the requisite experience for the positions in question, and/or
(B) create a program to train City residents for those jobs, and to report to Ground Landlord, upon Ground Landlord’s request,
regarding the status of its consideration of such proposals (it being understood that Tenant shall not be required to hire any
candidate which Tenant, in good faith, considers unqualified for the applicable position).

 

(c)          Both
Landlord and Ground Landlord and their respective designees shall be beneficiaries of each such agreement by Tenant. Landlord hereby
reserves the right, on behalf of itself and Ground Landlord, and their respective designees, as such third party beneficiaries,
to seek specific performance by Tenant, at the expense of Tenant, of the aforesaid obligations contained in this Section 42.

 

43.         Prohibited
Distinctions. Tenant covenants and agrees to be bound by the following covenants, which
shall be binding for the benefit of Landlord and Ground Landlord and enforceable by Landlord and Ground Landlord against Tenant
to the fullest extent permitted by law and equity:

 

(a)          Tenant
(and any lessees of the Premises or any part thereof) shall comply with all applicable federal, state, and local laws in effect
from time to time prohibiting discrimination or segregation by reason of age, race, creed, religion, sex, color, national origin,
ancestry, sexual orientation or affectional preference, disability, or marital status (collectively, “Prohibited
Distinctions”) in the lease or occupancy of the Premises.

 

(b)          Tenant
shall not effect or execute any agreement, lease, conveyance, or other instrument whereby the lease or occupancy of the Premises,
or any part thereof, is restricted upon the basis of any Prohibited Distinction.

 

(c)          Tenant
(and any lessees of the Premises or any part thereof) shall include the covenants of (a) and (b) in any agreement, sublease, conveyance,
or other instrument with respect to the lease or occupancy of the Premises.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 40

    

 

44.         IDA
Lease Requirements. Tenant shall provide, and shall cause any subtenant or other occupant
of the Premises to provide, to Landlord and to any other entity specified by Landlord in writing, the information that Landlord
needs in order to satisfy the reporting requirements set forth in the provisions of the IDA Lease (excerpted on Exhibit M hereto),
as the same may be modified from time to time by the governmental entities requiring the same. Tenant represents, and shall cause
and subtenant or other occupant of the Premises to represent with respect to itself (in place of “Tenant”), that either:
(A) Tenant’s occupancy at the Project will not result in the removal of a plant or facility of Tenant located outside of
the City, but within the State of New York, to the Project or in the abandonment of one or more of such plants or facilities of
such Tenant located outside of the City but within the State of New York or (B) Tenant’s location at the Project is reasonably
necessary to discourage Tenant from removing its business to a location outside of the State of New York or is reasonably necessary
to preserve Tenant’s competitive position in its industry.

 

45.         ICIP.
Landlord hereby notifies Tenant that Landlord intends to avail itself of the Industrial
and Commercial Incentive Program (“ICIP”). In connection therewith,
all of Tenant’s construction managers, contractors and subcontractors employed in connection with construction work at the
Building shall be contractually required by Tenant to comply with the New York City Department of Small Business Services/Division
of Labor Services (“DLS”) requirements applicable to construction
projects benefiting from the ICIP. Such compliance, as of the date hereof, includes the following: the submission and approval
of a Construction Employment Report, attendance at a pre-construction conference with representatives of the DLS and adherence
to the provisions of Article 22 of the ICIP Rules and Regulations, the provisions of New York City Charter Chapter 13-B and the
provisions of Executive Order No. 50 (1980). Furthermore, at Landlord’s request, Tenant shall (A) report to Landlord the
number of workers permanently engaged in employment in the Premises, the nature of each worker’s employment and, to the
extent applicable, the New York City residency of each worker, (B) provide access to the Premises by employees and agents of the
Department (as such term is defined in the ICIP Rules and Regulations) at all reasonable times upon reasonable advance notice,
and (C) enforce the contractual obligations of Tenant’s construction managers, contractors and subcontractors to comply
with the DLS requirements.

 

46.         Release
of Portion(s) of the Project.  Landlord, at any time and from time to time, shall have the right to subdivide, transfer title
to, or enter into a ground lease or long-term net lease (a “Partial Conveyance”) of, or convert to a condominium
form of ownership, any portion of the Project (including, for example, by transferring one or more of the Project's buildings and/or
another portion or portions of the Project) to another Person not in Control of, Controlled by or under common Control with, Landlord,
which such Partial Conveyance may reduce the size of the Project. In the event of such a Partial Conveyance by Landlord, Landlord
and Tenant agree to enter into an amendment of this Lease in form reasonably satisfactory to Landlord and Tenant to adjust the
definitions of Real Property and Project, if necessary and in accordance with the conditions set forth in this Section 46,
to describe accurately the land and improvements constituting the remaining portion of the Land and Project after such Partial
Conveyance; to increase Tenant's Share, if necessary to reflect the transfer of the portion of the Land and/or the Project included
in such Partial Conveyance; and to make any other changes that may be necessary or appropriate so that Tenant continues to be responsible
for its other obligations, including the payment of Rental, under this Lease and to enjoy its rights and privileges under this
Lease, subject to and in accordance with this Section 46.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 41

    

 

47.         Shared
Work Area.

 

(a)          General
Provisions. Notwithstanding anything to the contrary herein, Tenant shall have a license, on a non-exclusive basis in common
with other tenants and users of the ninth floor of the Building, to use the Shared Work Area for the Permitted Use, in accordance
with the Rules and Regulations applicable thereto and all Legal Requirements, but such access and use shall be subject to the terms
of the Superior Instruments (as defined in Section 28). The Shared Work Area contains certain equipment, furnishings; systems,
and personal property, as more particularly described on Exhibit O attached hereto (collectively, the “Shared Work
Systems”). The license granted hereby is personal to Tenant and shall not, except as provided in the next sentence, be
assigned or otherwise pledged or transferred, directly or indirectly. In the case of a Permitted Assignment, Tenant shall have
no further right to use the Shared Work Area and the Shared Work Systems in accordance with the terms and conditions of this Lease;
provided, however, that the following shall have the non-exclusive license to use the Shared Work Systems in accordance with the
terms and conditions of this Lease: (i) a subtenant approved by Landlord in accordance with the provisions of this Lease that subleases
50% or more of the Premises, and (ii) an assignee permitted under a Permitted Assignment.

 

(b)          Relocation/Modification
of Shared Work Area. Landlord shall have the right at any time and from time to time in the exercise of its sole and absolute
subjective discretion to reconfigure, relocate, or modify the Shared Work Area and to revise, expand, suspend, terminate, or discontinue
any of the Shared Work Systems. Landlord shall provide reasonable notice to Tenant of the relocation, suspension, termination,
or discontinuance of any Shared Work Systems as long as Landlord has actual knowledge of any such relocation, suspension, termination,
or discontinuance.

 

(c)          Interference.
Tenant shall use the Shared Work Area and the Shared Work Systems in a manner that will not interfere with the rights of any tenants
or occupants in the Building or users of the Shared Work Area or the providers of the services associated with the Shared Work
Systems. Landlord assumes no responsibility for enforcing Tenant’s rights or for protecting the Shared Work Area from any
person or entity, including, but not limited to, other tenants or occupants of the Building or users of the Shared Work Area.

 

(d)          Limitations.
Landlord’s sole obligation for providing the Shared Work Systems shall be: (A) to provide the Shared Work Systems as is determined
by Landlord in the exercise of its sole and absolute subjective discretion, and (B) to contract with one or more third parties
to maintain the Shared Work Systems that are deemed by Landlord in the exercise of its sole and absolute subjective discretion
to need periodic maintenance in accordance with the manufacturer’s or supplier’s standard guidelines or otherwise.
During any period of replacement, repair, or maintenance of the Shared Work Systems when they are not operational (including, but
not limited to, any delays thereto due to the inability to obtain parts or replacements), Landlord shall have no obligation to
provide Tenant with alternative, supplemental, temporary, or back-up Shared Work Systems. Tenant acknowledges and agrees that,
because the Shared Work Area and Shared Work Systems are provided for the benefit of all tenants and users of the fourth and fifth
floors of the Building, Landlord may reduce the Shared Work Area and/or Shared Work Systems and/or the resources therein from time
to time in response to a lack of usage by such tenants or obsolescence or similar reasons and users and may increase, replace or
otherwise modify the Shared Work Area and/or Shared Work Systems and/or resources therein from time to time in response to the
needs of such tenants and users. Landlord shall have no liability for any such reduction, increase, replacement or modification
of the Shared Work Area and/or Shared Work Systems, and none of the foregoing shall reduce the Base Rent payable by Tenant hereunder.
Tenant acknowledges and agrees that increases, replacements and/or modifications of the Shared Work Area and/or Shared Work Systems
may result in an increase in Operating Expenses (SWA), and Tenant agrees to pay Tenant's Share (SWA) of any such increase in accordance
with Section 47(h) below. The terms and provisions of this paragraph shall survive the expiration or earlier termination
of this Lease.

 

(e)          No
Warranties. Landlord makes no warranties of any kind, express or implied, with respect to the Shared Work Area and Shared Work
Systems, and Landlord disclaims any such warranties. Without limiting the foregoing, Tenant expressly acknowledges and agrees that
Landlord does not guaranty or warrant that the Shared Work Systems will be operational at all times, will be of sufficient capacity
to accommodate Tenant’s use thereof, will be free of Hazardous Materials, or will function or perform adequately, and Landlord
shall not be liable for any damages resulting from the failure of the Shared Work Systems.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 42

    

 

(f)          Other
Lease Provisions. Although the Shared Work Area does not form a part of the Premises, the provisions of this Lease (A) governing
Tenant’s use, operation, and enjoyment of the Premises, (B) imposing obligations on Tenant for matters occurring in, on,
within, or about the Premises or arising out of the use or occupancy of the Premises (including, but not limited to, those obligations
relating to insurance, indemnification, Hazardous Materials Clearance, and environmental requirements triggered by Tenant’s
use of the Shared Work Area), and (C) limiting Landlord’s liability, shall apply with equal force to Tenant’s use of
the Shared Work Area and the Shared Work Systems.

 

(g)          Termination.
If Tenant Defaults in its obligations under this Section 47, Landlord shall have the right, in addition to any other rights
and remedies available to Landlord for a Default by Tenant, to terminate immediately Tenant’s license to use the Shared Work
Area. The expiration or earlier termination of this Lease shall automatically terminate the license hereby granted to Tenant to
so use the Shared Work Area.

 

(h)          Shared
Work Area Operating Expenses.

 

(i)          Shared
Work Area Operating Expense Payments. Landlord shall deliver to Tenant an Annual Estimate of Operating Expenses (SWA) for each
calendar year during the Term, which may be revised by Landlord from time to time during such calendar year. During each month
of the Term, on the same date that Base Rent is due, Tenant shall pay Landlord, as Additional Rent hereunder, an amount equal to
1/12th of Tenant's Share (SWA) of the Annual Estimate of Operating Expenses (SWA). Payments for any fractional calendar month shall
be prorated.

 

(ii)         The
term “Operating Expenses (SWA)” means all costs and expenses of maintaining, repairing, replacing and operating
the Shared Work Area and the Shared Work Systems incurred or accrued each calendar year by Landlord and Tenant with respect to
their respective shares.

 

(iii)        Each
Annual Statement shall include (a) the total and Tenant's Share (SWA) of actual Operating Expenses (SWA) for the previous calendar
year and (b) the total of Tenant’s payments in respect of Tenant's Share (SWA) of actual Operating Expenses (SWA) for such
year. If Tenant's Share (SWA) of actual Operating Expenses (SWA) for such year exceeds Tenant’s payments of Tenant's Share
(SWA) of Operating Expenses (SWA) for such year, then the excess shall be due and payable by Tenant as Rent within 30 days after
delivery of such Annual Statement to Tenant. If Tenant's payments of Operating Expenses (SWA) for such year exceed Tenant's Share
(SWA) of actual Operating Expenses (SWA) for such year, then Landlord shall pay the excess to Tenant within 30 days after delivery
of such Annual Statement, except that after the expiration, or earlier termination of the Term or if Tenant is delinquent in its
obligation to pay Rent, Landlord shall pay the excess to Tenant after deducting all other amounts due Landlord. Operating Expenses
(SWA) for the calendar years in which Tenant’s obligation to share therein begins and ends shall be prorated. 

 

48.         Miscellaneous.

 

(a)          Notices.
All notices or other communications between the parties shall be in writing and shall be deemed duly given upon delivery or refusal
to accept delivery by the addressee thereof if delivered in person, or upon actual receipt if delivered by reputable overnight
guaranty courier, addressed and sent to the parties at their addresses set forth above. Landlord and Tenant may from time to time
by written notice to the other designate another address for receipt of future notices.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 43

    

 

(b)          Joint
and Several Liability. If and when included within the term “Tenant,” as used in this instrument, there
is more than one person or entity, each shall be jointly and severally liable for the obligations of Tenant.

 

(c)          Recordation.
Neither this Lease nor a memorandum of lease shall be filed by or on behalf of Tenant in any public record. Landlord may prepare
and file, and upon request by Landlord Tenant will execute, a memorandum of lease. Each such memorandum shall include such matters
as may be required by the Register of New York County or Section 291-c of the Real Property Law of the State of New York to be
included therein so as to permit the same to be recorded.

 

(d)          Interpretation.
The normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed
in the interpretation of this Lease or any exhibits or amendments hereto. Words of any gender used in this Lease shall be held
and construed to include any other gender, and words in the singular number shall be held to include the plural, unless the context
otherwise requires. The captions inserted in this Lease are for convenience only and in no way define, limit or otherwise describe
the scope or intent of this Lease, or any provision hereof, or in any way affect the interpretation of this Lease.

 

(e)          Not
Binding Until Executed. The submission by Landlord to Tenant of this Lease shall have no binding force or effect, shall not
constitute an option for the leasing of the Premises, nor confer any right or impose any obligations upon either party until execution
of this Lease by both parties.

 

(f)          Limitations
on Interest. It is expressly the intent of Landlord and Tenant at all times to comply with applicable law governing the maximum
rate or amount of any interest payable on or in connection with this Lease. If applicable law is ever judicially interpreted so
as to render usurious any interest called for under this Lease, or contracted for, charged, taken, reserved, or received with respect
to this Lease, then it is Landlord’s and Tenant’s express intent that all excess amounts theretofore collected by Landlord
be credited on the applicable obligation (or, if the obligation has been or would thereby be paid in full, refunded to Tenant),
and the provisions of this Lease immediately shall be deemed reformed and the amounts thereafter collectible hereunder reduced,
without the necessity of the execution of any new document, so as to comply with the applicable law, but so as to permit the recovery
of the fullest amount otherwise called for hereunder.

 

(g)          Time.
Time is of the essence as to the performance of Tenant’s obligations under this Lease.

 

(h)          Incorporation
by Reference. All exhibits and addenda attached hereto are hereby incorporated into this Lease and made a part hereof. If there
is any conflict between such exhibits or addenda and the terms of this Lease, such exhibits or addenda shall control.

 

49.         Landlord
Consent.

 

(a)          If,
pursuant to the terms of this Lease, any consent or approval by Landlord or Tenant is not to be unreasonably withheld or is subject
to a specified standard, then in the event of a final determination that the consent or approval was unreasonably withheld or that
such specified standard has been met (such that the consent or approval should have been granted), the consent or approval shall
be deemed granted but the granting of the consent or approval shall be the only remedy to the party requesting or requiring the
consent or approval.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 44

    

 

(b)          If
any matter which is the subject of a request for consent or approval hereunder by Tenant requires the consent or approval by any
Superior Party under the Superior Instruments (including, by way of example, proposed Alterations), Tenant shall submit in writing
such request (together with any plans, specifications or other materials or documents necessary or appropriate in connection therewith)
to Landlord, and Landlord shall, provided Tenant is not then in monetary or material non-monetary default hereunder, in each instance,
beyond the expiration of any applicable notice and/or cure period, promptly forward such request to such of the foregoing parties
from whom consent is required and otherwise cooperate reasonably with Tenant in requesting and seeking to obtain such required
consent; and, in any such case, Landlord shall in no event be deemed to have unreasonably withheld or delayed any such request
for consent or approval if any of the foregoing parties shall fail to respond to such request (unless such failure is deemed to
constitute consent under the applicable Superior Instrument) or shall deny same. If Landlord shall so determine that any such matter
requires the consent or approval of any of the foregoing parties, Landlord shall use good faith reasonable efforts to obtain from
such parties such consent or approval (but without any obligation to pay any fee to such party unless Tenant agrees to pay the
same); provided that Tenant shall submit to Landlord, upon Landlord’s request therefor, all plans, specifications or other
materials, information or documentation as may be reasonably required by such parties, under the Superior Instruments in connection
with each such parties’ respective consideration of such request. Tenant shall pay to Landlord, within thirty (30) days after
demand therefor, as Additional Rent, all actual out-of-pocket fees, charges or other expenses Landlord may incur arising out of
any such request for consent or approval. In no event shall Tenant communicate (other than through Landlord) with any Superior
Party in respect of any Alterations or any other matter pertaining to this Lease.

 

50.         Hazardous
Activities. Notwithstanding any other provision of this Lease, Landlord, for itself and its employees, agents and contractors,
reserves the right to refuse to perform any repairs or services in any portion of the Premises which, pursuant to Tenant’s
routine safety guidelines, practices or custom or prudent industry practices, require any form of protective clothing or equipment
other than safety glasses. In any such case, Tenant shall contract with parties who are acceptable to Landlord, in Landlord’s
reasonable discretion, for all such repairs and services, and Landlord shall, to the extent required, equitably adjust Tenant’s
Share of Operating Expenses in respect of such repairs or services to reflect that Landlord is not providing such repairs or services
to Tenant. 

 

51.         Internet
Service. It is currently anticipated that wireless internet service (“Internet Service”) will be available
in the Common Areas and Open Space in the Project. In the event that Internet Service is so available, Tenant shall have the right,
on a non-exclusive basis in common with other tenants and users of the Project, to use such Internet Service, subject to the further
terms of this Section 51.

 

(a)          Tenant
acknowledges that Landlord is not the generator of Internet Service and that the availability and quality of Internet Service consequently
is subject to the provision of the same to the Project by the third party provider(s) responsible for delivering same to the Project.
Landlord shall have no liability for the availability, capacity, quality, continuity or character of service of Internet Service,
and no abatement of Rent or other penalty shall arise due to, nor shall Landlord have any liability due to any loss, cost, claim,
damage or expense arising from the availability, capacity, quality, continuity or character of service of Internet Service or any
interruption, deterioration or removal of Internet Service. Tenant acknowledges that the capacity of Internet Service available
for use by Tenant (if any) is part of the overall capacity of Internet Service available to the Project for use on a non-exclusive
basis in common with all other tenants at the Project. Tenant agrees to limit Tenant's use of Internet Service to Tenant's reasonable
share of the then-existing capacity of Internet Service, and Tenant shall not use Internet Service in a manner that interferes
with any other tenant’s or user's use of such Internet Service.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 45

    

 

(b)          By
accessing or using Internet Service, Tenant accepts and agrees to comply with all terms and conditions applicable thereto (including
any modifications and/or additions thereto provided in connection with accessing or using Internet Service from time to time).

 

(c)          Tenant
acknowledges and agrees that all information (including, without limitation, data files, written text, computer software, music,
audio files or other sounds, photographs, graphics, videos or other images) which Tenant may have access to as a part of, or through
Tenant's use of, Internet Service (collectively, “Content”) is the sole responsibility of the person from whom
such Content originated. Tenant acknowledges and agrees that by using Internet Service, Tenant may be exposed to Content that Tenant
may find offensive, indecent or objectionable, and Tenant uses the Internet Service at its own risk. Landlord and any third party
provider(s) responsible for delivering Internet Service to the Project reserve the right (but shall have no obligation) to pre-screen,
review, flag, filter, modify, refuse or remove any or all Content from the Internet Service. Landlord does not control the Content
posted via the Internet Service and, as such, does not guarantee the accuracy, integrity, or quality of such Content. Under no
circumstances shall Landlord or any Superior Parties be liable in any way for any Content, including, without limitation, any errors
or omissions in any Content, or for any loss or damage arising out of or in connection with Tenant's use of the Internet Service
(including, without limitation, damages for loss of use, lost profits or loss of data or information of any kind).

 

(d)          Tenant
is solely responsible for maintaining Tenant's account for the use of Internet Service, and Tenant is fully responsible for all
activities that occur under Tenant's account and in connection with Tenant's use of the Internet Service. Tenant agrees to notify
Landlord and any third party provider(s) responsible for delivering Internet Service to the Project immediately of any unauthorized
use of Tenant's account or any other breaches of security of which Tenant becomes aware. Tenant is solely responsible for, and
shall indemnify, defend, and hold harmless Landlord and the Superior Parties for, any Content created, uploaded, posted, emailed,
transmitted, displayed or otherwise made available by Tenant via the Internet Service and for any and all consequences of Tenant's
use of the Internet Service (including, without limitation, any loss or damage suffered by Landlord or any Superior Parties arising
therefrom or in connection therewith).

 

(e)          Tenant
agrees not to use the Internet Service to:

 

(i)          upload,
post, email, transmit or otherwise make available any Content that is unlawful, harmful, threatening, abusive, harassing, tortious,
defamatory, vulgar, obscene, libelous, invasive of another's privacy, hateful, or racially, ethnically or otherwise objectionable;

 

(ii)         harm
minors in any way;

 

(iii)        impersonate
any person or entity or falsely state or otherwise misrepresent Tenant's affiliation with a person or entity;

 

(iv)        forge
headers or otherwise manipulate identifiers in order to disguise the origin of any Content transmitted through the Internet Service;

 

(v)         upload,
post, email, transmit or otherwise make available any Content that Tenant does not have a right to make available under any law
or under contractual or fiduciary relationships (such as inside information, proprietary and confidential information learned or
disclosed as part of employment relationships or under nondisclosure agreements);

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 46

    

 

(vi)        upload,
post, email, transmit or otherwise make available any Content that infringes any patent, trademark, trade secret, copyright or
other proprietary or intellectual property rights of any party;

 

(vii)       upload,
post, email, transmit or otherwise make available any unsolicited or unauthorized advertising, promotional materials, “junk
mail,” “spam,” “chain letters,” “pyramid schemes,” or any other form of solicitation,
except in those areas (such as shopping) that are designated for such purpose;

 

(viii)      upload,
post, email, transmit or otherwise make available any material that contains software viruses or any other computer code, files
or programs designed to interrupt, destroy or limit the functionality of any computer software or hardware or telecommunications
equipment;

 

(ix)         disrupt
the normal flow of dialogue, cause a screen to “scroll” faster than other users of the Internet Services are able to
type, or otherwise act in a manner that negatively affects other users' ability to engage in real time exchanges;

 

(x)          interfere
with or disrupt the Internet Services or servers or networks connected to the Internet Services, or disobey any requirements, procedures,
policies or regulations of networks connected to the Internet Services, including using any device, software or routine to bypass
our robot exclusion headers;

 

(xi)         intentionally
or unintentionally violate any applicable local, state, national or international law, including, but not limited to, regulations
promulgated by the U.S. Securities and Exchange Commission, any rules of any national or other securities exchange, including,
without limitation, the New York Stock Exchange, the American Stock Exchange or the NASDAQ, and any regulations having the force
of law;

 

(xii)        provide
material support or resources (or to conceal or disguise the nature, location, source, or ownership of material support or resources)
to any organization(s) designated by the United States government as a foreign terrorist organization pursuant to Section 219 of
the Immigration and Nationality Act;

 

(xiii)       “stalk”
or otherwise harass another; or

 

(xiv)      collect
or store personal data about other users in connection with the prohibited conduct and activities set forth in clauses (i)
through (xiii) above.

 

(f)          Tenant
acknowledges, consents to and agrees that Landlord and/or any third party provider(s) responsible for delivering Internet Service
to the Project may access, preserve and disclose Tenant's account information associated with the Internet Service if required
to do so by applicable Legal Requirements or in a good faith belief that such access, preservation or disclosure is reasonably
necessary to (i) comply with legal process, (ii) comply with the directives of law enforcement officials, (iii) enforce
the provisions of this Section 51 and/or the terms and conditions applicable to the Internet Service from time to time,
(iv) respond to claims that any Content violates the rights of third parties, (v) respond to Tenant's requests for customer
service, and/or (vi) protect the rights, property or personal safety of Landlord, the Superior Parties, any third party provider(s)
responsible for delivering Internet Service to the Project, any users of Internet Service, any tenants or other occupants of the
Project and the public.

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 47

    

 

(g)          Tenant
acknowledges and agrees that the Internet Service may include security components that permit digital materials to be protected,
and that the use of these materials is subject to such usage rules as may be set by Landlord, any third party provider(s) responsible
for delivering Internet Service to the Project, and/or any Content provider(s). Tenant shall not attempt to override or circumvent
any of such usage rules, and any unauthorized reproduction, publication, further distribution or public exhibition of the materials
provided on the Internet Service, in whole or in part, is strictly prohibited.

 

[ Signatures on next page ]

 

    	

    	Net/Office/Laboratory	430 East 29th Street, NY, NY/Immune Pharma, Inc. - Page 48

    

 

IN WITNESS WHEREOF,
Landlord and Tenant have executed this Lease as of the day and year first above written.

 

	 	TENANT:
	 	 
	 	IMMUNE PHARMACEUTICALS, INC., 
	 	a Delaware corporation
	 	 
	 	By:	/s/ Dr.
    Daniel Teper 
	 	Name:	Dr. Daniel Teper
	 	Title:	Chief Executive Officer
	 	 
	 	LANDLORD:
	 	 
	 	ARE-EAST RIVER SCIENCE PARK, LLC,
	 	a Delaware limited liability company
	 	 
	 	By:	/s/ ALEXANDRIA
    REAL ESTATE EQUITIES, L.P.,
	 	Name: 	a Delaware limited partnership,
	 	Title: 	managing member
	 	 
	 	 	By:	/s/ ARE-QRS
    CORP.,
	 	 	Name:	a Maryland corporation,
	 	 	Title	general partner
	 	 
	 	 	 	By: 	 
	 	 	 	Its:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}]]